{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:27:00Z","timestamp":1795224420659,"version":"4.10.3"},"reference-count":940,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":4778,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/j.1600-6143.2009.02834.x","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T15:52:01Z","timestamp":1255535521000},"page":"S1-S155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1111,"special_numbering":"S3","title":["Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients"],"prefix":"10.1016","volume":"9","author":[{"given":"Kai-Uwe","family":"Eckardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram L.","family":"Kasiske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2009.02834.x_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib3","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/ndt\/gfp174","article-title":"The cost-effectiveness of induction immunosuppression in kidney transplantation","volume":"24","author":"Morton","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1681\/ASN.V8111771","article-title":"Effect of anti-lymphocyte induction therapy on renal allograft survival: A meta-analysis","volume":"8","author":"Szczech","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-128-10-199805150-00004","article-title":"The effect of antilymphocyte induction therapy on renal allograft survival. A meta-analysis of individual patient-level data. Anti-Lymphocyte Antibody Induction Therapy Study Group","volume":"128","author":"Szczech","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/ndt\/13.3.711","article-title":"Advantage of antithymocyte globulin induction in sensitized kidney recipients: A randomized prospective study comparing induction with and without antithymocyte globulin","volume":"13","author":"Thibaudin","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/01.TP.0000056635.59888.EF","article-title":"A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients","volume":"75","author":"Charpentier","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib8","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib9","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1600-6143.2008.02273.x","article-title":"Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: Results of a prospective randomized trial","volume":"8","author":"Margreiter","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib10","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/01.tp.0000263344.53000.a1","article-title":"Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation","volume":"83","author":"Thomas","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/01.tp.0000166921.14670.33","article-title":"Randomized trial of Alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation","volume":"80","author":"Vathsala","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.tp.0000165847.05787.08","article-title":"A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring","volume":"80","author":"Ciancio","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1399-0012.2007.00774.x","article-title":"A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up","volume":"22","author":"Ciancio","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-6143.2005.01198.x","article-title":"Obesity and outcome following renal transplantation","volume":"6","author":"Gore","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl. 3","key":"10.1111\/j.1600-6143.2009.02834.x_bib15","first-page":"iii38","article-title":"Acute rejection and late renal transplant failure: Risk factors and prognosis","volume":"19","author":"Pallardo Mateu","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1399-3046.2000.00117.x","article-title":"A decade of living donor transplantation in North American children: The 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"4","author":"McDonald","year":"2000","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0041-1345(03)00306-3","article-title":"Risk factors for acute rejection in 806 cyclosporine-treated renal transplants: A multivariate analysis","volume":"35","author":"Mota","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1523-1755.2000.00235.x","article-title":"Delayed graft function influences renal function, but not survival","volume":"58","author":"Boom","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.tp.0000255583.34329.dd","article-title":"Living donor kidney transplantation: The effects of donor age and gender on short- and long-term outcomes","volume":"83","author":"Oien","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/ndt\/gfl042","article-title":"Major effects of delayed graft function and cold ischaemia time on renal allograft survival","volume":"21","author":"Quiroga","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1034\/j.1600-6143.2002.20907.x","article-title":"The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients","volume":"2","author":"Sagedal","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ndt\/gfh739","article-title":"Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results","volume":"20","author":"Kramer","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.TP.0000162980.68628.5A","article-title":"A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients","volume":"80","author":"Hardinger","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2005030249","article-title":"No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year","volume":"17","author":"Rowshani","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib27","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/bjs.4134","article-title":"Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis","volume":"90","author":"Murphy","year":"2003","journal-title":"Br J Surg"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.TP.0000154915.20524.0A","article-title":"Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation","volume":"79","author":"Rostaing","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-6143.2006.01645.x","article-title":"Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study","volume":"7","author":"Ekberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib31","first-page":"391","article-title":"Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial","volume":"68","year":"1999","journal-title":"European Mycophenolate Mofetil Cooperative Study Group. Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199902150-00012","article-title":"A prospective, randomized trial of tacrolimus\/prednisone versus tacrolimus\/prednisone\/mycophenolate mofetil in renal transplant recipients","volume":"67","author":"Shapiro","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/TP.0b013e3181952623","article-title":"Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: A systematic review","volume":"87","author":"Knight","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-200003150-00035","article-title":"Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506\/MMF Dose-Ranging Kidney Transplant Study Group","volume":"69","author":"Miller","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(04)16808-6","article-title":"Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): A randomised trial","volume":"364","author":"Remuzzi","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00007890-200208270-00013","article-title":"Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study","volume":"74","author":"Sadek","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib39","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib40","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/TP.0b013e318199c1c7","article-title":"Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation","volume":"87","author":"Opelz","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib41","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/TP.0b013e31819e86cd","article-title":"The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes?","volume":"87","author":"Craig","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib44","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1681\/ASN.V11101910","article-title":"A meta-analysis of immunosuppression withdrawal trials in renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib45","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.TP.0000140969.43761.1F","article-title":"Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials","volume":"78","author":"Pascual","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1600-6143.2004.00419.x","article-title":"Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: A prospective, randomized, multicenter study","volume":"4","author":"ter Meulen","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib47","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2007.02057.x","article-title":"A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients","volume":"8","author":"Vincenti","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib49","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1600-6143.2008.02272.x","article-title":"Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients","volume":"8","author":"Kasiske","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib50","first-page":"CD004290","article-title":"Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients","author":"Webster","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib51","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":"Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids","volume":"7","author":"Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00007890-200209270-00012","article-title":"Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients","volume":"74","author":"Langer","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.TP.0000072016.13090.4E","article-title":"Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: A matched-pair pilot study","volume":"76","author":"Troppmann","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib54","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1034\/j.1600-6143.2003.00185.x","article-title":"Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation","volume":"3","author":"Valente","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib55","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/01.TP.0000123082.31092.53","article-title":"Wound-healing complications after kidney transplantation: A prospective, randomized comparison of sirolimus and tacrolimus","volume":"77","author":"Dean","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib56","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/sj.ki.5001792","article-title":"Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients","volume":"70","author":"Van Den Akker","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib57","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/01.tp.0000219703.39149.85","article-title":"Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib58","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1111\/j.1600-6143.2006.01320.x","article-title":"Severe diarrhea in renal transplant patients: Results of the DIDACT study","volume":"6","author":"Maes","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1440-1797.1996.tb00068.x","article-title":"Dialysis in developing countries: Priorities and obstacles","volume":"2","author":"Jha","year":"1996","journal-title":"Nephrology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib60","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/S0041-1345(99)00722-8","article-title":"Economics of dialysis and renal transplantation in the developing world","volume":"31","author":"Chugh","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1492-7535.2003.00044.x","article-title":"The practice of dialysis in the developing countries","volume":"7","author":"Jha","year":"2003","journal-title":"Hemodialysis International"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/ajkd.2001.20596","article-title":"Impact of cyclosporine withdrawal on living related renal transplants: A single-center experience","volume":"37","author":"Jha","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib63","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(82)91544-6","article-title":"Cyclosporin interaction with ketoconazole and melphalan","volume":"2","author":"Morgenstern","year":"1982","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib64","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.1990.03450040018004","article-title":"Cyclosporine-ketoconazole combination offers promise in reducing antirejection therapy costs","volume":"264","author":"Randall","year":"1990","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib65","first-page":"1709","article-title":"Ketoconazole in posttransplant triple therapy: Comparison of costs and outcomes","volume":"24","author":"Gueco","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib66","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00007890-199305000-00009","article-title":"Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial","volume":"55","author":"First","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib66a","first-page":"351","article-title":"Prospective study of the safety and financial benefit of ketoconazole as adjuntive therapy to cyclosporine after heart transplantation","volume":"10","author":"Butman","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib67","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00007890-199403270-00021","article-title":"A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome","volume":"57","author":"Patton","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib68","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJM199509073331004","article-title":"Ketoconazole to reduce the need for cyclosporine after cardiac transplantation","volume":"333","author":"Keogh","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib69","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/ajkd.2001.22075","article-title":"Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: Long-term follow-up and study of metabolic consequences","volume":"37","author":"Sobh","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0041-1345(02)03839-3","article-title":"Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipients","volume":"35","author":"Abraham","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib71","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/01.TP.0000122343.51904.C3","article-title":"Cyclosporine and low-dose ketoconazole in renal transplant recipients: A single-center experience","volume":"77","author":"Carbajal","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib72","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.TP.0000112935.43362.37","article-title":"Sirolimus and ketoconazole co-prescription in renal transplant recipients","volume":"77","author":"Thomas","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000094133","article-title":"Ketoconazole-tacrolimus coadministration in kidney transplant recipients: Two-year results of a prospective randomized study","volume":"26","author":"El-Dahshan","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib73a","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0041-1345(03)00450-0","article-title":"Coadministration of tacrolimus and ketoconazole in renal transplant recipients: Cost analysis and review of metabolic effects","volume":"35","author":"Soltero","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib74","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/01.TP.0000121133.84763.26","article-title":"A prospective, randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients: Ten-year follow-up","volume":"77","author":"El-Agroudy","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib75","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/ndt\/gfh191","article-title":"Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: A prospective randomized study","volume":"19","author":"El-Dahshan","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00228-004-0745-0","article-title":"The use of a cyclosporin-ketoconazole combination: Making renal transplantation affordable in developing countries","volume":"60","author":"Gerntholtz","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib77","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0041-1345(98)00393-5","article-title":"Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants","volume":"30","author":"Foradori","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib78","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.transproceed.2004.09.011","article-title":"Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole","volume":"37","author":"Videla","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib79","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.transproceed.2006.06.037","article-title":"Tacrolimus (Pan Graf) as de novo therapy in renal transplant recipients in India","volume":"38","author":"Guleria","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib80","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.transproceed.2007.01.056","article-title":"Tacrolimus (Pan Graf) in live related renal transplantation: An initial experience of 101 recipients in India","volume":"39","author":"Guleria","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib81","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.transproceed.2008.07.084","article-title":"Generic tacrolimus (Pan Graf) in renal transplantation: An experience of 155 recipients in India","volume":"40","author":"Guleria","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib82","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib83","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/01.tp.0000203306.72858.df","article-title":"Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: A prospective randomized single-center pilot study","volume":"81","author":"Kyllonen","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib84","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FTD.0b013e31819c6a37","article-title":"Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib85","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/ndt\/17.8.1487","article-title":"C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients","volume":"17","author":"Jorgensen","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib86","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ftd.0000199358.80013.bd","article-title":"Therapeutic drug monitoring of mycophenolate mofetil in transplantation","volume":"28","author":"Van Gelder","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib87","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/TP.0b013e3181744199","article-title":"Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review","volume":"85","author":"Knight","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib88","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2007.01983.x","article-title":"Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation","volume":"7","author":"Le Meur","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib89","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"Van Gelder","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib91","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.V133759","article-title":"The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic Acid in pediatric renal transplant recipients: A report of the german study group on mycophenolate mofetil therapy","volume":"13","author":"Weber","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00007691-200002000-00004","article-title":"Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients","volume":"22","author":"Oellerich","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib93","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1600-6143.2004.00455.x","article-title":"Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation","volume":"4","author":"Kiberd","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib94","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/FTD.0b013e31802c5cf5","article-title":"The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: Recent developments","volume":"28","author":"Oellerich","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib95","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00007890-200110150-00001","article-title":"Rapamycin: Clinical results and future opportunities","volume":"72","author":"Kahan","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib96","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1365-2125.1999.00085.x","article-title":"Entry-into-human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients","volume":"48","author":"Neumayer","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib97","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007691-200410000-00007","article-title":"Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation","volume":"26","author":"Kovarik","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib98","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1517\/13543784.11.12.1845","article-title":"Review of the proliferation inhibitor everolimus","volume":"11","author":"Nashan","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib99","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: Updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib100","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.V9112129","article-title":"Beneficial effects of treatment of early subclinical rejection: A randomized study","volume":"9","author":"Rush","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib101","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1034\/j.1399-0012.1999.130601.x","article-title":"Does subclinical rejection contribute to chronic rejection in renal transplant patients?","volume":"13","author":"Rush","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib102","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/j.1600-6143.2007.01979.x","article-title":"Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study","volume":"7","author":"Rush","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib103","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-6143.2007.02049.x","article-title":"The utility of 1- and 3-month protocol biopsies on renal allograft function: A randomized controlled study","volume":"8","author":"Kurtkoti","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib104","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/00007890-200206270-00023","article-title":"Subclinical rejection in tacrolimus-treated renal transplant recipients","volume":"73","author":"Gloor","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib105","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.tp.0000215178.72344.9d","article-title":"Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: A systematic review of randomized trial data","volume":"81","author":"Webster","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib106","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/00007890-200104270-00014","article-title":"Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: Three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group","volume":"71","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib107","first-page":"231","article-title":"A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients","volume":"11","author":"Mariat","year":"1998","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib108","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/j.1600-6143.2008.02411.x","article-title":"A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation","volume":"8","author":"Zarkhin","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib109","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff \u201805 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib111","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib112","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/j.1600-6143.2005.00926.x","article-title":"Workshop on late renal allograft dysfunction","volume":"5","author":"Meyers","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib113","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib114","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.tp.0000190423.82154.01","article-title":"Chronic allograft nephropathy: Current concepts and future directions","volume":"81","author":"Nankivell","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib115","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2215\/CJN.05271008","article-title":"Management of chronic allograft nephropathy: A systematic review","volume":"4","author":"Birnbaum","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1 Suppl 3","key":"10.1111\/j.1600-6143.2009.02834.x_bib116","first-page":"261","article-title":"TRANCEPT - A prospective observational global clinical study of patients switched to MMF at least 6 months after renal transplantation","volume":"82","author":"Meier-Kriesche","year":"2006","journal-title":"Abstract 578 Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib117","first-page":"466","article-title":"Transplantation","volume":"79","author":"Dudley","year":"2005"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib118","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/TP.0b013e31816b4388","article-title":"Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study","volume":"85","author":"Shihab","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib119","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00007890-198210000-00008","article-title":"Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants","volume":"34","author":"Carlier","year":"1982","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib121","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ncpneph0376","article-title":"When should post-transplantation proteinuria be attributed to the renal allograft rather than to the native kidney?","volume":"3","author":"Morath","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib122","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007890-200108150-00014","article-title":"Proteinuria after renal transplantation affects not only graft survival but also patient survival","volume":"72","author":"Roodnat","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib123","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1600-6143.2007.01836.x","article-title":"Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause","volume":"7","author":"Sis","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib124","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/j.1523-1755.2004.00662.x","article-title":"Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy","volume":"65","author":"Sijpkens","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib125","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/j.1600-6143.2005.01050.x","article-title":"Predicting subsequent decline in kidney allograft function from early surveillance biopsies","volume":"5","author":"Cosio","year":"2005","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib126","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-200868001-00005","article-title":"Mechanisms and management of proteinuria in kidney transplant patients","volume":"68","author":"Barama","year":"2008","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib127","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ncpneph0854","article-title":"A primer on recurrent and de novo glomerulonephritis in renal allografts","volume":"4","author":"Ivanyi","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib128","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/01.tp.0000288807.52520.5e","article-title":"C4d-positive chronic rejection: A frequent entity with a poor outcome","volume":"84","author":"David-Neto","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib129","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00007890-200204270-00028","article-title":"The risk of cardiovascular disease associated with proteinuria in renal transplant patients","volume":"73","author":"Fernandez-Fresnedo","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/ndt\/gfh002","article-title":"Proteinuria after renal transplantation: Pathogenesis and management","volume":"19","author":"Reichel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib131","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00000658-200007000-00014","article-title":"Chronic allograft failure in human renal transplantation: A multivariate risk factor analysis","volume":"232","author":"McLaren","year":"2000","journal-title":"Ann Surg"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib132","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/j.1600-6143.2007.02010.x","article-title":"Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients","volume":"7","author":"Halimi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib133","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archinte.1987.00370050135022","article-title":"Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples","volume":"147","author":"Schwab","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib134","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM198312223092503","article-title":"Use of single voided urine samples to estimate quantitative proteinuria","volume":"309","author":"Ginsberg","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib135","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/0272-6386(95)90054-3","article-title":"The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group","volume":"26","author":"Rodby","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib136","first-page":"110","article-title":"Quantitation of proteinuria in kidney transplant patients: Accuracy of the urinary protein\/creatinine ratio","volume":"43","author":"Steinhauslin","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib137","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1681\/ASN.V76930","article-title":"Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin\/creatinine ratio","volume":"7","author":"Warram","year":"1996","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib138","first-page":"S1","article-title":"American Diabetes Association clinical practice recommendations 2001","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib139","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","volume":"105","author":"Hogg","year":"2000","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib140","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","article-title":"National Kidney Foundation\u2019s K\/DOQI clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification","volume":"111","author":"Hogg","year":"2003","journal-title":"Pediatrics"},{"issue":"2 Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib141","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib142","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","article-title":"Serum creatinine as an index of renal function: New insights into old concepts","volume":"38","author":"Perrone","year":"1992","journal-title":"Clin Chem"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib143","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.me.39.020188.002341","article-title":"Serum creatinine and renal function","volume":"39","author":"Levey","year":"1988","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib144","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/ajkd.2002.31996","article-title":"A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure","volume":"39","author":"Kasiske","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib145","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/ajkd.2001.28605","article-title":"Comparing methods for monitoring serum creatinine to predict late renal allograft failure","volume":"38","author":"Kasiske","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib146","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5414\/CNP70018","article-title":"Is Cystatin C more sensitive than creatinine in detecting early chronic allograft nephropathy?","volume":"70","author":"Ortiz","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib147","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/ndt\/gfn505","article-title":"Body mass does not have a clinically relevant effect on cystatin C eGFR in children","volume":"24","author":"Sharma","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib148","first-page":"153","article-title":"The values of estimated glomerular filtration rate calculated with creatinine and cystatin C based equations in healthy adults","volume":"54","author":"Dajak","year":"2008","journal-title":"Clin Lab"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib149","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":"Predicting glomerular filtration rate after kidney transplantation","volume":"59","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib150","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/j.ajkd.2008.02.308","article-title":"Performance of creatinine-based estimates of GFR in kidney transplant recipients: A systematic review","volume":"51","author":"White","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib151","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/j.ajkd.2007.06.013","article-title":"Testing for chronic kidney disease: A position statement from the National Kidney Foundation","volume":"50","author":"Vassalotti","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib152","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clinbiochem.2006.10.014","article-title":"How to estimate GFR-serum creatinine, serum cystatin C or equations?","volume":"40","author":"Herget-Rosenthal","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib153","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1258\/0004563054889936","article-title":"Estimating kidney function in adults using formulae","volume":"42","author":"Lamb","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib154","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/ajkd.1998.v32.pm9669420","article-title":"Assessing renal function from creatinine measurements in adults with chronic renal failure","volume":"32","author":"Walser","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2125.1997.t01-1-00567.x","article-title":"Predictive performance of renal function estimate equations in renal allografts","volume":"44","author":"Goerdt","year":"1997","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 63","key":"10.1111\/j.1600-6143.2009.02834.x_bib156","first-page":"S151","article-title":"Measurement of glomerular filtration rate","author":"Gaspari","year":"1997","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib157","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00007890-198909000-00014","article-title":"Creatinine excretion after renal transplantation","volume":"48","author":"Kasiske","year":"1989","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib158","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/TP.0b013e3181788aea","article-title":"Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients","volume":"86","author":"Oterdoom","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib159","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1600-6143.2005.01224.x","article-title":"Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy","volume":"6","author":"Schwenger","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib160","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/ndt\/9.12.1822","article-title":"New diagnostic techniques in clinical nephrology. Colour coded duplex sonography for evaluation of renal transplants-tool or toy for the nephrologist?","volume":"9","author":"Hollenbeck","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib161","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00345-004-0412-1","article-title":"The role of imaging techniques in renal transplantation","volume":"22","author":"Burgos","year":"2004","journal-title":"World J Urol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib162","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00261-005-0394-5","article-title":"Imaging of the renal transplant: Comparison of MRI with duplex sonography","volume":"31","author":"Browne","year":"2006","journal-title":"Abdom Imaging"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib163","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1600-6143.2008.02160.x","article-title":"Course and relevance of arteriovenous fistulas after renal transplant biopsies","volume":"8","author":"Schwarz","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib164","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib165","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000092017","article-title":"OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection","volume":"103","author":"Patschan","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib166","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1046\/j.1523-1755.1998.00071.x","article-title":"Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys","volume":"54","author":"Giral-Classe","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib167","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/00007890-200211270-00010","article-title":"Silent acute rejection during prolonged delayed graft function reduces kidney allograft survival","volume":"74","author":"Qureshi","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib168","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/TP.0b013e318169c29e","article-title":"Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression","volume":"85","author":"Mikhalski","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib169","first-page":"2576","article-title":"Protocol biopsies in stable renal transplant patients under triple immunosuppression: Results at 6 months","volume":"26","author":"Rush","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib170","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-200102270-00006","article-title":"Effect of histological damage on long-term kidney transplant outcome","volume":"71","author":"Nankivell","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib171","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-6143.2001.010109.x","article-title":"An analysis of early renal transplant protocol biopsies-the high incidence of subclinical tubulitis","volume":"1","author":"Shapiro","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib172","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ndt\/17.6.1081","article-title":"Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts","volume":"17","author":"Gough","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib173","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.TP.0000128167.60172.CC","article-title":"Natural history, risk factors, and impact of subclinical rejection in kidney transplantation","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib174","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.TP.0000118905.98469.91","article-title":"Subclinical rejection and borderline changes in early protocol biopsy specimens after renal transplantation","volume":"77","author":"Roberts","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib175","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1600-6143.2006.01436.x","article-title":"The significance of subclinical rejection and the value of protocol biopsies","volume":"6","author":"Nankivell","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib176","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00007890-199502270-00012","article-title":"Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema","volume":"59","author":"Rush","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib177","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.ASN.0000056189.02819.32","article-title":"The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy","volume":"14","author":"Shishido","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 10","key":"10.1111\/j.1600-6143.2009.02834.x_bib178","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1399-0012.17.s10.6.x","article-title":"Histological evaluation of renal allograft protocol biopsies in the early period and 1 year after transplantation","volume":"17","author":"Kanetsuna","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib179","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1600-6143.2005.00830.x","article-title":"Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center","volume":"5","author":"Choi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib180","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/ndt\/13.4.975","article-title":"Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases","volume":"13","author":"Hergesell","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib181","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.transproceed.2005.03.138","article-title":"The pathologic impact of tacrolimus on protocol biopsy in renal transplant patients with basiliximab-based immunosuppression","volume":"37","author":"Sakai","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib182","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/01.TP.0000137268.85155.11","article-title":"Baseline immunosuppression is associated with histological findings in early protocol biopsies","volume":"78","author":"Moreso","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib183","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.transproceed.2003.11.056","article-title":"Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies","volume":"36","author":"Toz","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib184","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/01.TP.0000121134.96928.0E","article-title":"Complications of protocol renal biopsy","volume":"77","author":"Fereira","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib185","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/00007890-199011000-00010","article-title":"Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies","volume":"50","author":"Wilczek","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib186","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.TP.0000082542.99416.11","article-title":"Protocol biopsy of the stable renal transplant: A multicenter study of methods and complication rates","volume":"76","author":"Furness","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib187","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/j.1600-6143.2005.00988.x","article-title":"Safety and adequacy of renal transplant protocol biopsies","volume":"5","author":"Schwarz","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib188","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1600-6143.2006.01677.x","article-title":"Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis","volume":"7","author":"Mengel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib189","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/ajkd.1998.v31.pm9631835","article-title":"Recurrent and de novo renal diseases after renal transplantation: A report from the renal allograft disease registry","volume":"31","author":"Hariharan","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2215\/CJN.04050907","article-title":"Recurrent glomerulonephritis after renal transplantation: An unsolved problem","volume":"3","author":"Golgert","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib191","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1600-6143.2005.00968.x","article-title":"New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis","volume":"5","author":"Vincenti","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib192","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1399-3046.2003.00151.x","article-title":"Recurrence of primary disease in children after renal transplantation: An evidence-based update","volume":"8","author":"Seikaly","year":"2004","journal-title":"Pediatr Transplant"},{"issue":"Suppl 6","key":"10.1111\/j.1600-6143.2009.02834.x_bib193","first-page":"vi68","article-title":"Recurrent disease in renal transplants","volume":"18","author":"Newstead","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib194","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/j.1600-6143.2006.01361.x","article-title":"Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant","volume":"6","author":"Myslak","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jca.10007","article-title":"Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: Re-analysis of published case-reports and case-series","volume":"16","author":"Davenport","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib196","first-page":"271","article-title":"Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients","volume":"56","author":"Matalon","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib197","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ndt\/gfh173","article-title":"Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: Theory and therapy","volume":"19","author":"Ghiggeri","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib198","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients","volume":"5","author":"Gohh","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib199","first-page":"17","article-title":"Management of recurrent nephrotic syndrome after kidney transplantation in children","volume":"46","author":"Cochat","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib200","first-page":"1345","article-title":"Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis","volume":"25","author":"Mowry","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib201","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/j.1600-6143.2006.01502.x","article-title":"Recurrent glomerulonephritis after kidney transplantation","volume":"6","author":"Choy","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl 14","key":"10.1111\/j.1600-6143.2009.02834.x_bib202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-0012.2005.00403.x","article-title":"Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation","volume":"19","author":"Moriyama","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib203","first-page":"941","article-title":"Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy","volume":"21","author":"Bantis","year":"2008","journal-title":"J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib204","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1399-0012.2007.00730.x","article-title":"Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation","volume":"21","author":"Coppo","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib205","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00007890-199711270-00024","article-title":"Recurrent immunoglobulin A nephropathy after renal transplantation: A significant contributor to graft loss","volume":"64","author":"Ohmacht","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib206","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ndt\/15.5.689","article-title":"A clinicopathological study of IgA nephropathy in renal transplant recipients: Beneficial effect of angiotensin-converting enzyme inhibitor","volume":"15","author":"Oka","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib207","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181705ad4","article-title":"Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary IgA nephropathy","volume":"85","author":"Berthoux","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib208","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1097\/00007890-199706150-00016","article-title":"Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: Analysis of the incidence, risk factors, and impact on graft survival","volume":"63","author":"Andresdottir","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib209","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ki.5000084","article-title":"Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk","volume":"69","author":"Little","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib210","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0272-6386(00)70211-3","article-title":"Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation","volume":"35","author":"Lien","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib211","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0272-6386(00)70025-4","article-title":"Recurrent type I membranoproliferative glomerulonephritis in a renal allograft: Successful treatment with plasmapheresis","volume":"35","author":"Saxena","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jca.10026","article-title":"Management of membranoproliferative glomerulonephritis type II with plasmapheresis","volume":"17","author":"Kurtz","year":"2002","journal-title":"J Clin Apher"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib213","first-page":"418","article-title":"Regression of recurrent membranoproliferative glomerulonephritis type II in a transplanted kidney after plasmapheresis therapy","volume":"20","author":"Oberkircher","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib214","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1399-0012.1997.tb00772.x","article-title":"Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation","volume":"11","author":"Ahsan","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib216","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-200108270-00033","article-title":"Recurrence of hemolytic uremic syndrome after renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study","volume":"72","author":"Quan","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib217","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00467-003-1289-8","article-title":"The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children","volume":"18","author":"Loirat","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib218","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/oxfordjournals.ndt.a027673","article-title":"Renal transplantation in adults with thrombotic thrombocytopenic purpura\/haemolytic-uraemic syndrome","volume":"11","author":"Conlon","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib219","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00005792-200003000-00003","article-title":"Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l\u2019Ile-de-France (GCIF)","volume":"79","author":"Lahlou","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/01.TP.0000085083.74065.1B","article-title":"Renal transplantation in patients with hemolytic uremic syndrome: High rate of recurrence and increased incidence of acute rejections","volume":"76","author":"Artz","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib221","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1600-6143.2003.00222.x","article-title":"Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation","volume":"3","author":"Karthikeyan","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib222","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","article-title":"Hemolytic uremic syndrome recurrence after renal transplantation","volume":"12","author":"Loirat","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib223","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mpd.2001.112649","article-title":"Familial hemolytic uremic syndrome associated with complement factor H deficiency","volume":"138","author":"Landau","year":"2001","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib224","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(02)08560-4","article-title":"Combined kidney and liver transplantation for familial haemolytic uraemic syndrome","volume":"359","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib225","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-6143.2007.02029.x","article-title":"Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H","volume":"8","author":"Jalanko","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib226","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2215\/CJN.02170508","article-title":"Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome","volume":"4","author":"Saland","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib227","first-page":"733","article-title":"Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin","volume":"16","author":"Banerjee","year":"2003","journal-title":"J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib228","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1399-0012.2005.00334.x","article-title":"Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome","volume":"19","author":"Yassa","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib229","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1046\/j.1523-1755.1999.00666.x","article-title":"Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis","volume":"56","author":"Nachman","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib230","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/sj.ki.5002244","article-title":"Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression","volume":"71","author":"Gera","year":"2007","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib231","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/rheumatology\/33.9.869","article-title":"Recurrence of Wegener\u2019s granulomatosis following renal transplantation","volume":"33","author":"Rosenstein","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib232","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/00007890-199705150-00014","article-title":"Systemic vasculitis in a kidney transplant population","volume":"63","author":"Nyberg","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib233","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00007890-199012000-00030","article-title":"Treatment of Wegener\u2019s granulomatosis after renal transplantation: Is cyclosporine the preferred treatment?","volume":"50","author":"Clarke","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib234","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1016\/S0272-6386(03)00917-X","article-title":"Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation","volume":"42","author":"Lobbedez","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib235","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1111\/j.1600-6143.2007.01988.x","article-title":"Renal transplantation in the ANCA-associated vasculitides","volume":"7","author":"Geetha","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib236","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/j.1600-6143.2007.01985.x","article-title":"Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: Report of two cases","volume":"7","author":"Geetha","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib237","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0272-6386(99)70193-9","article-title":"Biopsy-proven resolution of immune complex-mediated crescentic glomerulonephritis with mycophenolate mofetil therapy in an allograft","volume":"33","author":"Adams","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib238","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5414\/CNP59212","article-title":"Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation","volume":"59","author":"Harzallah","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib239","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5414\/CNP68322","article-title":"Successful therapeutic use of rituximab in refractory Wegener\u2019s granulomatosis after renal transplantation","volume":"68","author":"Hermle","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib240","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","article-title":"Mycophenolate mofetil for maintenance therapy of Wegener\u2019s granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement","volume":"10","author":"Nowack","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib241","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ndt\/gfg393","article-title":"Recurrence of anti-GBM disease 8 years after renal transplantation","volume":"19","author":"Khandelwal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib242","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00007890-200209150-00020","article-title":"Renal allograft survival in patients with oxalosis","volume":"74","author":"Cibrik","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib243","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.tp.0000168147.88707.80","article-title":"Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: An alternative for type 1 primary hyperoxaluria","volume":"80","author":"Onaca","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib244","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00467-006-0124-4","article-title":"Primary hyperoxaluria type 1: Still challenging!","volume":"21","author":"Cochat","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib245","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.ajkd.2007.08.027","article-title":"Primary hyperoxaluria: Clinical course, diagnosis, and treatment after kidney failure","volume":"51","author":"Raju","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib246","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ki.2009.32","article-title":"The primary hyperoxalurias","volume":"75","author":"Hoppe","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib247","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ki.2008.63","article-title":"[13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria","volume":"73","author":"Sikora","year":"2008","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib248","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1523-1755.2004.00842.x","article-title":"Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias","volume":"66","author":"Rumsby","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib249","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00864405","article-title":"Management of primary hyperoxaluria: Efficacy of oral citrate administration","volume":"7","author":"Leumann","year":"1993","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib250","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199412083312304","article-title":"Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria","volume":"331","author":"Milliner","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib251","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/ndt\/gfm813","article-title":"Agalsidase therapy in patients with Fabry disease on renal replacement therapy: A nationwide study in Italy","volume":"23","author":"Mignani","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib252","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/TP.0b013e318191a842","article-title":"Kidney transplant outcomes in patients with Fabry disease","volume":"87","author":"Shah","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib253","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1523-1755.2004.00514.x","article-title":"Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study","volume":"65","author":"Mignani","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib254","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1016\/j.transproceed.2007.09.010","article-title":"Kidney transplantation and enzyme alpha-galactosidase A therapy in patient with Fabry disease: A case report","volume":"39","author":"Dziemianko","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-6143.2008.02495.x","article-title":"Nonadherence consensus conference summary report","volume":"9","author":"Fine","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib256","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib257","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/ajkd.2001.28923","article-title":"Maintenance immunosuppression in the renal transplant recipient: An overview","volume":"38","author":"Gaston","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib258","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib259","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF02850081","article-title":"Medication adherence and persistence: A comprehensive review","volume":"22","author":"Krueger","year":"2005","journal-title":"Adv Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib260","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2165\/00003495-200767100-00007","article-title":"Medication noncompliance and its implications in transplant recipients","volume":"67","author":"Morrissey","year":"2007","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib261","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1600-6143.2004.00537.x","article-title":"Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients","volume":"4","author":"Vlaminck","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib262","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1399-3046.2004.00158.x","article-title":"Impact of non-compliance on outcome after pediatric kidney transplantation: An analysis in racial subgroups","volume":"8","author":"Jarzembowski","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib263","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1600-6143.2004.00565.x","article-title":"Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant","volume":"4","author":"Yen","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib264","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.TP.0000110408.83054.88","article-title":"Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review","volume":"77","author":"Butler","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib265","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1016\/S0041-1345(99)00118-9","article-title":"Late renal allograft loss: Noncompliance masquerading as chronic rejection","volume":"31","author":"Gaston","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib266","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/01.TP.0000158430.06507.87","article-title":"Prevalence and correlates of self-reported pretransplant nonadherence with medication in heart, liver, and lung transplant candidates","volume":"79","author":"Dobbels","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib267","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1557(199901\/02)8:1<1::AID-PDS382>3.0.CO;2-4","article-title":"Potential utility of electronic drug compliance monitoring in measures of adverse outcomes associated with immunosuppressive agents","volume":"8","author":"Feldman","year":"1999","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib268","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.TP.0000110412.20050.36","article-title":"Measuring compliance with drug regimens after renal transplantation: Comparison of self-report and clinician rating with electronic monitoring","volume":"77","author":"Butler","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl A","key":"10.1111\/j.1600-6143.2009.02834.x_bib269","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/17.suppl_A.8","article-title":"Patient non-compliance with drug regimens: Measurement, clinical correlates, economic impact","volume":"17","author":"Urquhart","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib270","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1600-6143.2007.02127.x","article-title":"Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients","volume":"8","author":"Schafer-Keller","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib271","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ajhp\/60.7.657","article-title":"Meta-analysis of trials of interventions to improve medication adherence","volume":"60","author":"Peterson","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib272","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0163-8343(00)00098-0","article-title":"Noncompliance in organ transplant recipients: A literature review","volume":"22","author":"Laederach-Hofmann","year":"2000","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib273","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1525-1497.2004.30418.x","article-title":"Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection","volume":"19","author":"Schneider","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib274","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/ndt\/gfh505","article-title":"Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: A cross-sectional study","volume":"19","author":"Butler","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib275","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1034\/j.1399-3046.149.ptr1s077.1.x","article-title":"Non-compliance and its management in teenagers","volume":"6","author":"Nevins","year":"2002","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib276","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0022-3476(80)80653-6","article-title":"Evaluation of an educational program on compliance with medication regimens in pediatric patients with renal transplants","volume":"96","author":"Beck","year":"1980","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib277","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1399-3046.2005.00356.x","article-title":"Growing pains: Non-adherence with the immunosuppressive regimen in adolescent transplant recipients","volume":"9","author":"Dobbels","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib278","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/00005650-199808000-00004","article-title":"Effectiveness of interventions to improve patient compliance: A meta-analysis","volume":"36","author":"Roter","year":"1998","journal-title":"Med Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib279","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/432877","article-title":"A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment","volume":"41","author":"Andrade","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib280","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/09540120310001618630","article-title":"Use of an on-line pager system to increase adherence to antiretroviral medications","volume":"15","author":"Safren","year":"2003","journal-title":"AIDS Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib281","first-page":"155","article-title":"Medication noncompliance in patients with chronic disease: Issues in dialysis and renal transplantation","volume":"9","author":"Loghman-Adham","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib282","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007890-199907150-00010","article-title":"Medication compliance following renal transplantation","volume":"68","author":"Raiz","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib283","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007890-199301000-00010","article-title":"A study of treatment compliance following kidney transplantation","volume":"55","author":"Kiley","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib284","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib285","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1399-0012.2001.150505.x","article-title":"Impact of clinical pharmacy services on renal transplant patients\u2019 compliance with immunosuppressive medications","volume":"15","author":"Chisholm","year":"2001","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib286","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archinte.167.6.540","article-title":"Interventions to enhance medication adherence in chronic medical conditions: A systematic review","volume":"167","author":"Kripalani","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib287","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1399-0012.2006.00493.x","article-title":"Supporting medication adherence in renal transplantation (SMART): A pilot RCT to improve adherence to immunosuppressive regimens","volume":"20","author":"De Geest","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib288","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1399-3046.2007.00681.x","article-title":"The challenges of using medication event monitoring technology with pediatric transplant patients","volume":"11","author":"Shellmer","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"Suppl 10","key":"10.1111\/j.1600-6143.2009.02834.x_bib289","first-page":"160","article-title":"Guidelines for vaccination of solid organ transplant candidates and recipients","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib290","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1086\/313823","article-title":"Immunization of pediatric solid organ transplant candidates and recipients","volume":"30","author":"Burroughs","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib291","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0891-5520(05)70279-8","article-title":"Vaccines for transplant recipients","volume":"15","author":"Molrine","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib292","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1745-7599.2006.00163.x","article-title":"Safety of live-virus vaccines for children with immune deficiency","volume":"18","author":"Luthy","year":"2006","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib293","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1542\/peds.2007-0164","article-title":"Prevention of influenza: Recommendations for influenza immunization of children, 2006-2007","volume":"119","year":"2007","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib294","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1159\/000119742","article-title":"Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: A controlled trial","volume":"28","author":"Keshtkar-Jahromi","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib295","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-200002150-00023","article-title":"Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine","volume":"69","author":"Sanchez-Fructuoso","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib296","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib297","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib298","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib299","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/j.1600-6143.2006.01403.x","article-title":"BK virus infection in transplant recipients: An overview and update","volume":"6","author":"Randhawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib300","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib301","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/TP.0b013e31816a33d4","article-title":"Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study","volume":"85","author":"Almeras","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib302","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM200503173521125","article-title":"Leflunomide for polyomavirus type BK nephropathy","volume":"352","author":"Williams","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib303","first-page":"298","article-title":"Cytomegalovirus infection after organ transplantation. In: Bowden R, Ljungman P, Paya C (eds). Transplant infections, 2nd ed","author":"Paya","year":"2003","journal-title":"Lippincott, Williams and Wilkins"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib304","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007890-199201000-00013","article-title":"Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3","volume":"53","author":"Hibberd","year":"1992","journal-title":"Transplantation"},{"issue":"Suppl 10","key":"10.1111\/j.1600-6143.2009.02834.x_bib305","first-page":"51","article-title":"Cytomegalovirus","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib306","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","author":"Hodson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib307","first-page":"CD005129","article-title":"Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients","author":"Hodson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib308","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.tp.0000183970.71366.da","article-title":"Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients","volume":"81","author":"Strippoli","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib309","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-123-1-199507010-00002","article-title":"Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial","volume":"123","author":"Hibberd","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib311","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archsurg.1992.01420010065009","article-title":"A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy","volume":"127","author":"Stratta","year":"1992","journal-title":"Arch Surg"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib312","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"Asberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib313","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/342601","article-title":"Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease","volume":"186","author":"Humar","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib314","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1128\/JCM.38.2.768-772.2000","article-title":"Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation","volume":"38","author":"Weinberg","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-6135.2004.00728.x","article-title":"Epstein-Barr virus and lymphoproliferative disorders after transplantation","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib316","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00007890-199307000-00016","article-title":"Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center","volume":"56","author":"Cockfield","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib317","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids","volume":"8","author":"McDonald","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib318","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-3062.2001.003002079.x","article-title":"Epstein-Barr virus load monitoring: Its role in the prevention and management of post-transplant lymphoproliferative disease","volume":"3","author":"Rowe","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib319","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib320","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/infdis\/156.2.273","article-title":"Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation","volume":"156","author":"Breinig","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib321","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/j.1600-6143.2005.01002.x","article-title":"Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients","volume":"5","author":"Lee","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib322","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1600-6143.2006.01394.x","article-title":"CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients","volume":"6","author":"Green","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib323","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.2000.00895.x","article-title":"The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"36","author":"Harris","year":"2000","journal-title":"Histopathology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib324","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00007890-200104270-00010","article-title":"Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"71","author":"Dharnidharka","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib325","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: Report of 230 cases from the French Registry","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib326","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: A collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib327","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/snep.2001.24947","article-title":"Management of pediatric postrenal transplantation infections","volume":"21","author":"Dharnidharka","year":"2001","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib328","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1034\/j.1600-6143.2001.10202.x","article-title":"Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation","volume":"1","author":"Green","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib329","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004670050764","article-title":"Acyclovir prophylaxis of varicella in children with renal disease receiving steroids","volume":"14","author":"Goldstein","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib330","first-page":"711","article-title":"Varicella-zoster infections. In: Pickering L, Baker C, Long S, McMillan J (eds). Red book: 2006 report of the committee on infectious disease of the American Academy of Pediatrics, 27th edn.","year":"2006","journal-title":"American Academy of Pediatrics: Elk Grove Village, IL"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib331","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00007890-198803000-00031","article-title":"Transmission of fatal herpes simplex infection through renal transplantation","volume":"45","author":"Koneru","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib332","first-page":"5","article-title":"Cytomegalo and herpes simplex virus infections in renal transplant recipients","volume":"92","author":"Wertheim","year":"1985","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib333","first-page":"66","article-title":"Guidelines for the prevention and management of infectious complications of solid organ transplantation: HHV-6, HHV-7, HHV-8, HSV-1 and -2, VZV","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib334","first-page":"513","article-title":"Viral infection in the renal transplant patient","volume":"19","author":"Rubin","year":"1983","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib335","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.transproceed.2006.08.060","article-title":"Varicella infection in adult renal allograft recipients: Experience at one center","volume":"38","author":"Rodriguez-Moreno","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib336","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/586903","article-title":"Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older","volume":"197","author":"Arora","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib337","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1742-1241.2006.01155.x","article-title":"The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster","volume":"61","author":"Kurokawa","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib338","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/00007890-200202270-00023","article-title":"Disseminated varicella infection in adult renal allograft recipients: Four cases and a review of the literature","volume":"73","author":"Fehr","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib339","first-page":"60","article-title":"Prevention of VZV infection in immunosuppressed patients using antiviral agents","volume":"13","author":"Boeckh","year":"2006","journal-title":"Herpes"},{"issue":"Suppl 109","key":"10.1111\/j.1600-6143.2009.02834.x_bib340","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","year":"2008","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib341","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1046\/j.1523-1755.2003.00017.x","article-title":"Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS","volume":"63","author":"Burdick","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib342","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1525-139X.2002.00051.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2000","volume":"15","author":"Tokars","year":"2002","journal-title":"Semin Dial"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib343","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007890-198709000-00009","article-title":"Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies","volume":"44","author":"Harnett","year":"1987","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib344","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.1995.177","article-title":"Chronic viral hepatitis and the management of chronic renal failure","volume":"47","author":"Martin","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib345","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/ajkd.2001.28590","article-title":"Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis","volume":"38","author":"Fabrizi","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib346","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1111\/j.1600-6143.2005.01113.x","article-title":"HBsAg seropositive status and survival after renal transplantation: Meta-analysis of observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib347","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.TP.0000161250.83392.73","article-title":"Natural history of hepatitis B and C in renal allograft recipients","volume":"79","author":"Aroldi","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib348","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1399-0012.1997.tb01027.x","article-title":"Hepatitis antigenemia and survival after renal transplantation","volume":"11","author":"Pfaff","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib349","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.510290123","article-title":"Impact of hepatitis B and C virus on kidney transplantation outcome","volume":"29","author":"Mathurin","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007890-199607270-00025","article-title":"The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection","volume":"62","author":"Fornairon","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib351","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jcv.2008.03.021","article-title":"Erratum to \u2018The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting\u2019[J. Clin. Virol. 41 (4) 2008 243\u2013254]","volume":"42","author":"Barclay","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib352","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3748\/wjg.14.2288","article-title":"Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients","volume":"14","author":"Jain","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib353","first-page":"227","article-title":"[Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]","volume":"41","author":"Altindis","year":"2007","journal-title":"Mikrobiyol Bul"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib354","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/08860220600925602","article-title":"Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients","volume":"28","author":"Yakaryilmaz","year":"2006","journal-title":"Ren Fail"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib355","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s10620-006-9421-9","article-title":"Is hepatitis C virus positivity a contributing factor to occult hepatitis B virus infection in hemodialysis patients?","volume":"51","author":"Kanbay","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib356","first-page":"327","article-title":"Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection","volume":"19","author":"Siagris","year":"2006","journal-title":"J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib357","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-3062.2005.00091.x","article-title":"Occult hepatitis B in renal transplant patients","volume":"7","author":"Peres","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib358","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0168-8278(02)00457-9","article-title":"Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection","volume":"38","author":"Besisik","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib359","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/ki.1995.498","article-title":"HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis","volume":"48","author":"Oesterreicher","year":"1995","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib360","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.20435","article-title":"Occult hepatitis B virus infection in a North American adult hemodialysis patient population","volume":"40","author":"Minuk","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib361","first-page":"1721","article-title":"Occult hepatitis B virus infection in chronic hemodialysis patients in Korea","volume":"55","author":"Gwak","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib362","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1365-2036.2005.02501.x","article-title":"Occult hepatitis B virus infection in dialysis patients: A multicentre survey","volume":"21","author":"Fabrizi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib363","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3748\/wjg.v12.i21.3420","article-title":"Prevalence of occult HBV infection in haemodialysis patients with chronic HCV","volume":"12","author":"Goral","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib364","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/01.TP.0000163468.80223.74","article-title":"Solid-organ transplantation in HBsAg-negative patients with antibodies to HBV core antigen: Low risk of HBV reactivation","volume":"79","author":"Knoll","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib365","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jcv.2004.10.006","article-title":"HBV reactivation after kidney transplantation","volume":"32","author":"Berger","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib366","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1432-2277.2006.00427.x","article-title":"Hepatitis B virus reactivation after renal transplantation: Report of two cases","volume":"20","author":"Savas","year":"2007","journal-title":"Transpl Int"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib367","first-page":"S135","article-title":"Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients","volume":"11","author":"Durlik","year":"1998","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib368","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.TP.0000116448.97841.6D","article-title":"Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: Meta-analysis of clinical trials","volume":"77","author":"Fabrizi","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib369","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/jhep.2002.36156","article-title":"Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients","volume":"36","author":"Chan","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib370","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1590\/S0100-879X2002000200008","article-title":"Lamivudine therapy for hepatitis B in renal transplantation","volume":"35","author":"Santos","year":"2002","journal-title":"Braz J Med Biol Res"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib371","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcv.2004.07.001","article-title":"Effects of long-term lamivudine therapy in renal-transplant patients","volume":"31","author":"Kamar","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib372","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/00042737-200412000-00022","article-title":"Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B","volume":"16","author":"Thabut","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib373","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1478-3231.2005.01171.x","article-title":"Lamivudine therapy for hepatitis B infection in post-renal transplant patients: Results after 36 months follow-up","volume":"25","author":"De Silva","year":"2005","journal-title":"Liver Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib374","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3748\/wjg.v11.i3.400","article-title":"Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation","volume":"11","author":"Lapinski","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib375","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/135965350501000611","article-title":"Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis","volume":"10","author":"Vigano","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib376","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/00007890-199712150-00025","article-title":"Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation","volume":"64","author":"Rostaing","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib377","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00007890-199808150-00025","article-title":"Lamivudine inhibits hepatitis B virus replication in kidney graft recipients","volume":"66","author":"Goffin","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib378","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00007890-199809270-00007","article-title":"Treatment of chronic hepatitis B with lamivudine in renal transplant recipients","volume":"66","author":"Jung","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib379","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00007890-200011150-00024","article-title":"Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients","volume":"70","author":"Kletzmayr","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib380","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0041-1345(00)01500-1","article-title":"Managing hepatitis B reactivation in renal transplant recipients: A 12-year review with emphasis on early detection and early use of lamivudine","volume":"32","author":"Tsai","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib381","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0041-1345(00)01260-4","article-title":"Treatment of chronic hepatitis B with lamivudine in renal allograft recipients","volume":"32","author":"Lewandowska","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib382","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0041-1345(99)00987-2","article-title":"Efficacy and safety of lamivudine in renal transplant patients with chronic hepatitis B","volume":"32","author":"Antoine","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib383","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/S0041-1345(00)01870-4","article-title":"Chronic hepatitis B treatment with lamivudine in kidney transplant patients","volume":"32","author":"Mouquet","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib384","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/00007890-200005270-00020","article-title":"HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients","volume":"69","author":"Fontaine","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib385","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1053\/ajkd.2001.28607","article-title":"Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients","volume":"38","author":"Lee","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib386","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00007890-200102150-00008","article-title":"Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: Comparison with salvage treatment after hepatic dysfunction with HBV recurrence","volume":"71","author":"Han","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib387","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/ndt\/16.11.2222","article-title":"Outcome of renal transplantation in hepatitis B surface antigen-positive patients after introduction of lamivudine","volume":"16","author":"Park","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib388","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0041-1345(00)02731-7","article-title":"Lamivudine in recurrent hepatitis B after renal transplantation","volume":"33","author":"Mosconi","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib389","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.transproceed.2005.12.047","article-title":"Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen","volume":"38","author":"Filik","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib390","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-3046.2006.00500.x","article-title":"Antiviral treatment of hepatitis B following solid organ transplantation in children","volume":"10","author":"Wirth","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib391","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-200208270-00001","article-title":"Management of chronic viral hepatitis before and after renal transplantation","volume":"74","author":"Gane","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib392","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1600-6143.2004.00467.x","article-title":"Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients","volume":"4","author":"Chan","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib393","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.tp.0000178305.39231.a2","article-title":"Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency","volume":"80","author":"Fontaine","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib394","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/gast.2002.37058","article-title":"Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection","volume":"123","author":"Lai","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib395","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/TP.0b013e3181806c8c","article-title":"Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients","volume":"86","author":"Kamar","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib396","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2036.2008.03731.x","article-title":"Review article: Current antiviral therapy of chronic hepatitis B","volume":"28","author":"Ayoub","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib397","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","article-title":"Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B","volume":"359","author":"Marcellin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib398","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-6135.2004.00729.x","article-title":"Solid organ transplantation in the HIV-infected patient","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib399","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/TP.0b013e318177884e","article-title":"Preliminary experience with renal transplantation in HIV+ recipients: Low acute rejection and infection rates","volume":"86","author":"Gruber","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib400","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes","volume":"8","author":"Roland","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib401","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1600-6143.2007.02007.x","article-title":"Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients","volume":"7","author":"Frassetto","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib402","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00042307-200203000-00007","article-title":"Urinary tract infections after renal transplantation","volume":"12","author":"Schmaldienst","year":"2002","journal-title":"Curr Opin Urol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib403","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(90)90337-D","volume":"89","author":"Fox","year":"1990","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib404","article-title":"Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial","author":"Hibberd","year":"1992","journal-title":"Online J Curr Clin Trials"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib405","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1086\/320905","article-title":"Management of urinary tract infections and lymphocele in renal transplant recipients","volume":"33","author":"Munoz","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"Suppl 10","key":"10.1111\/j.1600-6143.2009.02834.x_bib406","first-page":"135","article-title":"Pneumocystis jiroveci (formerly Pneumocystis carinii)","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib407","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"316","author":"Hughes","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib408","unstructured":"Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children. Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infections Diseases Society of America, the Pediatric Infections Diseases Society, and the American Academy of Pediatrics. Morbidity and Mortality Weekly Report 2009; 58(RR-11), pp. 1\u2013176."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib409","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02111870","article-title":"Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit","volume":"14","author":"Hennequin","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib410","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0003-4975(10)64191-4","article-title":"Comparison of biopsy-proven Pneumocystis carinii pneumonia in acquired immune deficiency syndrome patients and renal allograft recipients","volume":"38","author":"Sterling","year":"1984","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib411","first-page":"39","article-title":"European best practice guidelines for renal transplantation Section IV: Long-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib412","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1046\/j.1525-1594.2002.07069.x","article-title":"Posttransplant infections in the tropical countries","volume":"26","author":"Jha","year":"2002","journal-title":"Artif Organs"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib413","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ndt\/11.5.768","article-title":"Tuberculosis in renal transplant units","volume":"11","author":"Drobniewski","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib414","unstructured":"MMWR: Treatment of tuberculosis. Centers for Disease Control and Prevention. In (vol 52, RR11), Atlanta, GA, USA, American Thoracic Society, CDC, and Infectious Diseases Society of America, 2003, pp 1\u201377."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib415","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11255-004-6251-6","article-title":"Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient","volume":"36","author":"Agarwal","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib416","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00007890-197507000-00015","article-title":"Manko MA. Chemoprophylaxis for the prevention of tuberculosis in the immunosuppressed renal allograft recipient","volume":"20","author":"Thomas","year":"1975","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib417","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.transproceed.2006.06.010","article-title":"Efficacy of isoniazid prophylaxis in renal allograft recipients","volume":"38","author":"Naqvi","year":"2006","journal-title":"Transplant Proc"},{"issue":"Suppl 10","key":"10.1111\/j.1600-6143.2009.02834.x_bib418","first-page":"37","article-title":"Mycobacterium tuberculosis","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib419","first-page":"19","article-title":"Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis","volume":"44","year":"1995","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib420","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/ndt\/gfn748","article-title":"Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients","volume":"24","author":"Triverio","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib421","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-3062.2008.00348.x","article-title":"Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients","volume":"11","author":"Hursitoglu","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib422","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2215\/CJN.01010208","article-title":"Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients","volume":"3","author":"Winthrop","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib423","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00040007","article-title":"Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients","volume":"30","author":"Kobashi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib424","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007890-199601270-00008","article-title":"The high incidence of tuberculosis among renal transplant recipients in India","volume":"61","author":"Sakhuja","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib425","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1046\/j.1523-1755.1999.00746.x","article-title":"Successful management of pulmonary tuberculosis in renal allograft recipients in a single center","volume":"56","author":"Jha","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib426","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1023\/A:1025693521582","article-title":"Tuberculosis in renal transplant recipients: Rifampicin sparing treatment protocol","volume":"34","author":"Vachharajani","year":"2002","journal-title":"Int Urol Nephrol"},{"issue":"Suppl 10","key":"10.1111\/j.1600-6143.2009.02834.x_bib427","first-page":"110","article-title":"Fungal infections","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib428","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1399-0012.2001.150203.x","article-title":"Clotrimazole increases tacrolimus blood levels: A drug interaction in kidney transplant patients","volume":"15","author":"Vasquez","year":"2001","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib429","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ndt\/14.3.648","article-title":"Cardiovascular morbidity and risk factors in renal transplant patients","volume":"14","author":"Aakhus","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib430","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V1191735","article-title":"Explained and unexplained ischemic heart disease risk after renal transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib431","first-page":"380","article-title":"The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation","volume":"15","author":"Woo","year":"2002","journal-title":"J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib432","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1523-1755.2004.00751.x","article-title":"Predicting coronary heart disease in renal transplant recipients: A prospective study","volume":"66","author":"Ducloux","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib433","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-0012.2004.00235.x","article-title":"Cardiovascular disease in stable renal transplant patients in Norway: Morbidity and mortality during a 5-yr follow-up","volume":"18","author":"Aakhus","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib434","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2215\/CJN.00030108","article-title":"Cardiovascular outcomes in the outpatient kidney transplant clinic: The Framingham risk score revisited","volume":"3","author":"Kiberd","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib435","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","article-title":"Cardiovascular complications after renal transplantation and their prevention","volume":"82","author":"Ojo","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib436","unstructured":"USRDS 2007 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States In, Bethesda, MD, US Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib437","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1681\/ASN.2005090984","article-title":"Acute myocardial infarction and kidney transplantation","volume":"17","author":"Kasiske","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib438","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF02564867","article-title":"Cardiovascular risk factors and diseases after renal transplantation","volume":"30","author":"Aker","year":"1998","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib439","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/ndt\/12.8.1672","article-title":"Patient survival after renal transplantation; more than 25 years follow-up","volume":"12","author":"Arend","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib440","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1523-1755.1998.00787.x","article-title":"Patient survival after renal transplantation: I. The impact of dialysis pre-transplant","volume":"53","author":"Cosio","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib441","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0002-9343(88)90302-6","article-title":"Risk factors for accelerated atherosclerosis in renal transplant recipients","volume":"84","author":"Kasiske","year":"1988","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib442","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation","volume":"7","author":"Kasiske","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib443","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","article-title":"De novo congestive heart failure after kidney transplantation: A common condition with poor prognostic implications","volume":"46","author":"Lentine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib444","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1523-1755.2005.00303.x","article-title":"Clinical impact of preexisting vascular calcifications on mortality after renal transplantation","volume":"67","author":"Hernandez","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib445","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007890-200007270-00013","article-title":"Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease","volume":"70","author":"Humar","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib446","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-6143.2003.30114.x","article-title":"Determinants of cardiovascular mortality after renal transplantation: A role for cytomegalovirus?","volume":"3","author":"Kalil","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib447","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-6143.2005.01141.x","article-title":"Mortality after kidney transplantation: A comparison between the United States and Canada","volume":"6","author":"Kim","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib448","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00007890-199509000-00008","article-title":"Ischemic heart disease-major cause of death and graft loss after renal transplantation in Scandinavia","volume":"60","author":"Lindholm","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib449","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00007890-199304000-00014","article-title":"Half-life and risk factors for kidney transplant outcome-importance of death with function","volume":"55","author":"Matas","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0012.2003.02042.x","article-title":"Stroke in renal transplant recipients: Epidemiology, predictive risk factors and outcome","volume":"17","author":"Oliveras","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib451","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00007890-198607000-00006","article-title":"Multivariate analysis of risk factors in cadaver donor kidney transplantation","volume":"42","author":"Sanfilippo","year":"1986","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib452","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00007890-200010150-00010","article-title":"Peripheral vascular occlusive disease in renal transplant recipients: Risk factors and impact on kidney allograft survival","volume":"70","author":"Sung","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib453","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1523-1755.1999.00294.x","article-title":"Early graft function and patient survival following cadaveric renal transplantation","volume":"55","author":"Woo","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib454","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1432-2277.2006.00367.x","article-title":"The influence of obesity on short- and long-term graft and patient survival after renal transplantation","volume":"19","author":"Aalten","year":"2006","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib455","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1755.2003.00761.x","article-title":"Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index","volume":"63","author":"Glanton","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib456","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00007890-200201150-00013","article-title":"The impact of body mass index on renal transplant outcomes: A significant independent risk factor for graft failure and patient death","volume":"73","author":"Meier-Kriesche","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib457","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ki.1982.130","article-title":"Effect of alternate-day prednisone on plasma lipids in renal transplant recipients","volume":"22","author":"Curtis","year":"1982","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib458","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib459","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1681\/ASN.V5122073","article-title":"The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients","volume":"5","author":"Hilbrands","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib460","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1681\/ASN.V82294","article-title":"Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: A randomized study","volume":"8","author":"Hollander","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib461","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0272-6386(12)80095-3","article-title":"Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia","volume":"18","author":"Hricik","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib462","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199305000-00015","article-title":"The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era","volume":"55","author":"Ingulli","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib463","first-page":"14","article-title":"The effect of cyclosporin A on plasma lipids during the first year after renal transplantation","volume":"12","author":"John","year":"1999","journal-title":"Natl Med J India"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib464","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00007890-198801000-00012","article-title":"Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients","volume":"45","author":"Kupin","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib465","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1097\/00007890-200011150-00015","article-title":"Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection","volume":"70","author":"Vanrenterghem","year":"2000","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1111\/j.1600-6143.2009.02834.x_bib466","first-page":"S1","article-title":"National Kidney Foundation. K\/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease","volume":"41","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib467","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib468","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00007890-198902000-00016","article-title":"Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients","volume":"47","author":"Roth","year":"1989","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib469","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1399-0012.1994.tb00245.x","article-title":"Steroid-related complications in the cyclosporine era","volume":"8","author":"Fryer","year":"1994","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib470","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1399-0012.2001.150202.x","article-title":"Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation","volume":"15","author":"Revanur","year":"2001","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib471","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1046\/j.1523-1755.2001.059002732.x","article-title":"Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years","volume":"59","author":"Cosio","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib472","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","article-title":"Patient survival after renal transplantation: IV. Impact of post-transplant diabetes","volume":"62","author":"Cosio","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib473","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8227(01)00290-X","article-title":"High incidence of post-transplant diabetes mellitus in Kuwait","volume":"55","author":"Johny","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib474","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib475","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","article-title":"Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients","volume":"3","author":"Woodward","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib476","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1097\/01.ASN.0000145439.48387.BF","article-title":"Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus","volume":"15","author":"Abbott","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib477","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2004.00591.x","article-title":"Development of diabetes mellitus following kidney transplantation: A Canadian experience","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib478","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.arcmed.2006.05.004","article-title":"Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients","volume":"37","author":"Andrade-Sierra","year":"2006","journal-title":"Arch Med Res"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib479","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.tp.0000195770.31960.18","article-title":"Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs","volume":"81","author":"Araki","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib480","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00007890-200109270-00007","article-title":"Posttransplant diabetes mellitus in pediatric renal transplant recipients: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)","volume":"72","author":"Al-Uzri","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib481","first-page":"84","article-title":"Diabetes mellitus following paediatric renal transplantation: A single centre experience","volume":"67","author":"Sukthankar","year":"2007","journal-title":"Horm Res"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib482","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.annepidem.2004.10.003","article-title":"Differing manifestations of hepatitis C and tacrolimus on hospitalized diabetes mellitus occurring after kidney transplantation","volume":"15","author":"Abbott","year":"2005","journal-title":"Ann Epidemiol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib483","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-198712000-00010","article-title":"Thromboembolic complications in renal allograft recipients. A report from the prospective randomized study of cyclosporine versus azathioprine-antilymphocyte globulin","volume":"44","author":"Gruber","year":"1987","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib484","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-2277.2004.00043.x","article-title":"Post-transplant diabetes mellitus: Acase-control analysis of the risk factors","volume":"18","author":"Romagnoli","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib485","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/01.tp.0000250756.66348.9a","article-title":"Risk factors for development of new-onset diabetes mellitus after kidney transplantation","volume":"82","author":"Shah","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib486","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/j.1600-6143.2005.01051.x","article-title":"Prednisone-free maintenance immunosuppression-a 5-year experience","volume":"5","author":"Matas","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib487","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib488","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.tp.0000259617.21741.95","article-title":"Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients","volume":"83","author":"Burroughs","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib489","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.lfs.2006.09.034","article-title":"Functional and morphological study of cultured pancreatic islets treated with cyclosporine","volume":"80","author":"Ajabnoor","year":"2007","journal-title":"Life Sci"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib490","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1124\/mol.63.6.1289","article-title":"Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice","volume":"63","author":"Oetjen","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib491","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0168-8227(93)90017-Y","article-title":"Diabetogenic effects of FK506 on renal subcapsular islet isografts in rat","volume":"20","author":"Ueki","year":"1993","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib492","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-4274(95)03471-4","article-title":"Pancreatic and nephrotoxicity of immunomodulator compounds","volume":"82-83","author":"Hammond","year":"1995","journal-title":"Toxicol Lett"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib493","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1111\/j.1600-6143.2007.01946.x","article-title":"Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets","volume":"7","author":"Hernandez-Fisac","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib494","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.transproceed.2004.12.085","article-title":"Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus","volume":"37","author":"Oberholzer","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib495","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.transproceed.2005.03.137","article-title":"Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation","volume":"37","author":"Bouchta","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib496","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1681\/ASN.2005050487","article-title":"Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus","volume":"16","author":"Teutonico","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib497","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.transproceed.2006.03.072","article-title":"Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine","volume":"38","author":"Romagnoli","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib498","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study. The Rapamune US Study Group","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib499","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.tp.0000167757.63922.42","article-title":"A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year","volume":"80","author":"Mendez","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib500","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/01.TP.0000062837.99400.60","article-title":"Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 months","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib501","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000101495.22734.07","article-title":"A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate mofetil versus cyclosporine (NEORAL)\/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib502","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.tp.0000173378.28790.0b","article-title":"Comparison of steroid avoidance in tacrolimus\/mycophenolate mofetil and tacrolimus\/sirolimus combination in kidney transplantation monitored by surveillance biopsy","volume":"80","author":"Anil Kumar","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib503","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7326\/0003-4819-136-8-200204160-00006","article-title":"Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test?","volume":"136","author":"Stern","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib504","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2337\/diacare.28.2.404","article-title":"Predicting the development of diabetes in older adults: The derivation and validation of a prediction rule","volume":"28","author":"Kanaya","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib505","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diabetes.54.1.166","article-title":"Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes","volume":"54","author":"Lyssenko","year":"2005","journal-title":"Diabetes"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib506","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.diabres.2006.03.011","article-title":"Predictors of incident diabetes, metabolic syndrome in middle-aged adults: A 10-year follow-up study from Kinmen, Taiwan","volume":"74","author":"Sheu","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib507","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2337\/dc06-1816","article-title":"Gestational diabetes mellitus: Clinical predictors and long-term risk of developing type 2 diabetes: A retrospective cohort study using survival analysis","volume":"30","author":"Lee","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib508","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-147-6-200709180-00012","article-title":"Glycemic control and type 2 diabetes mellitus: The optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians","volume":"147","author":"Qaseem","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib509","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib510","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)80683-3","article-title":"Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial","volume":"75","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib511","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib512","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib513","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib514","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib515","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1056-8727(02)00277-5","article-title":"Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial","volume":"17","author":"Abraira","year":"2003","journal-title":"J Diabetes Complications"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib516","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jama.1994.03520080042041","article-title":"Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients","volume":"272","author":"Barbosa","year":"1994","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib517","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-199631020-00003","article-title":"Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency","volume":"31","author":"Harrower","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib518","first-page":"120","article-title":"Behaviour of chlorpropamide in renal insufficiency and under the effect of associated drug therapy","volume":"6","author":"Petitpierre","year":"1972","journal-title":"Int J Clin Pharmacol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib519","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00003088-198712060-00001","article-title":"The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs","volume":"12","author":"Ferner","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib520","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diab.14.6.362","article-title":"Serum concentration and urinary excretion of oral sulfonylurea compounds: Relation to diabetic control","volume":"14","author":"Sheldon","year":"1965","journal-title":"Diabetes"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib521","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0272-6386(00)70204-6","article-title":"Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease","volume":"35","author":"Krepinsky","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib522","article-title":"(eds). Drug facts and comparisons","author":"Wickersham","year":"2006","journal-title":"Wolters Kluwer Health, Inc: St. Louis, MO"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib523","first-page":"73","article-title":"Management of drugs affecting blood glucose in diabetic patients with renal failure","volume":"26","author":"Charpentier","year":"2000","journal-title":"Diabetes Metab"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib524","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.0894-0959.2004.17346.x","article-title":"Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease","volume":"17","author":"Snyder","year":"2004","journal-title":"Semin Dial"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib525","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.clpt.2005.07.005","article-title":"Cyclosporine markedly raises the plasma concentrations of repaglinide","volume":"78","author":"Kajosaari","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib526","first-page":"2564","article-title":"(eds). Merck index.","author":"O\u2019Neil","year":"2001","journal-title":"John Wiley & Sons: Hoboken, NJ"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib527","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1053\/ajkd.2002.33408","article-title":"Assessment of quality of life after simultaneous pancreas-kidney transplantation","volume":"39","author":"Sureshkumar","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib528","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1399-0012.1998.tb01097.x","article-title":"Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation","volume":"12","author":"Matas","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib529","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00007890-199609270-00009","article-title":"Comparison before and after transplantation of pancreas-kidney and pancreas-kidney with loss of pancreas-a prospective controlled quality of life study","volume":"62","author":"Adang","year":"1996","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib530","first-page":"S105","article-title":"Pancreas transplantation in type 1 diabetes","volume":"27","author":"Robertson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib531","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/j.1600-6143.2007.01957.x","article-title":"The islet transplant experiment: Time for a reassessment","volume":"7","author":"Bromberg","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib532","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1600-6143.2007.01923.x","article-title":"High risk of sensitization after failed islet transplantation","volume":"7","author":"Campbell","year":"2007","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib533","first-page":"S13","article-title":"Standards of medical care in diabetes-2009","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib534","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib535","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: A randomized controlled trial","volume":"300","author":"Ogawa","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib536","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib537","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00004872-200311000-00002","article-title":"World Health Organization (WHO)\/International Society of Hypertension (ISH) statement on management of hypertension","volume":"21","author":"Whitworth","year":"2003","journal-title":"J Hypertens"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib538","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib539","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib540","first-page":"1462","article-title":"2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib541","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/0003-4819-147-11-200712040-00009","article-title":"Screening for high blood pressure: US Preventive Services Task Force reaffirmation recommendation statement","volume":"147","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib542","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","article-title":"Hypertension after kidney transplantation","volume":"43","author":"Kasiske","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib543","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1681\/ASN.2006050543","article-title":"No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A collaborative transplant study report","volume":"17","author":"Opelz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib544","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","article-title":"Improved long-term outcomes after renal transplantation associated with blood pressure control","volume":"5","author":"Opelz","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib545","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study","volume":"53","author":"Opelz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib546","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.283.5.633","article-title":"Arterial hypertension and renal allograft survival","volume":"283","author":"Mange","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib547","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.ASN.0000104574.04006.08","article-title":"Blood pressure and the survival of renal allografts from living donors","volume":"15","author":"Mange","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib548","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00007890-200101150-00029","article-title":"Incidence of renal artery stenosis in pediatric en bloc and adult single kidney transplants","volume":"71","author":"Marques","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib549","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiology.219.3.r01jn30663","article-title":"Renal arterial stenosis in renal allografts: Retrospective study of predisposing factors and outcome after percutaneous transluminal angioplasty","volume":"219","author":"Patel","year":"2001","journal-title":"Radiology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib550","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.transproceed.2005.11.097","article-title":"Incidence and outcome of transplant renal artery stenosis: Single center experience","volume":"38","author":"Polak","year":"2006","journal-title":"Transplant Proc"},{"issue":"Suppl 68","key":"10.1111\/j.1600-6143.2009.02834.x_bib551","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1038\/sj.ki.4490573","article-title":"Renal artery stenosis after kidney transplantation: Diagnostic and therapeutic approach","author":"Rengel","year":"1998","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib552","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1600-6143.2005.00927.x","article-title":"Management of arterial stenosis affecting kidney graft perfusion: A single-centre study in 53 patients","volume":"5","author":"Voiculescu","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib553","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007890-199601270-00009","article-title":"Transplant renal artery stenosis in 77 patients-does it have an immunological cause?","volume":"61","author":"Wong","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib554","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(85)90627-0","article-title":"Benefits of removal of native kidneys in hypertension after renal transplantation","volume":"2","author":"Curtis","year":"1985","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib555","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/00007890-199805150-00007","article-title":"Treatment of posttransplant hypertension by laparoscopic bilateral nephrectomy?","volume":"65","author":"Fricke","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib556","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-5347(01)65166-8","article-title":"Laparoscopic bilateral nephrectomy: Results in 11 renal transplant patients","volume":"157","author":"Fornara","year":"1997","journal-title":"J Urol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib557","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib558","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0272-6386(12)81129-2","article-title":"Enalapril-associated anemia in renal transplant recipients treated for hypertension","volume":"17","author":"Vlahakos","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib559","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00007890-199309000-00018","article-title":"Anemia in renal transplant recipients caused by concomitant therapy with azathioprine and angiotensin-converting enzyme inhibitors","volume":"56","author":"Gossmann","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib560","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib561","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2007.04.013","article-title":"ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: A randomized clinical trial","volume":"50","author":"Paoletti","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib562","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(88)80331-0","article-title":"Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent","volume":"85","author":"Curtis","year":"1988","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib563","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00195908","article-title":"The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate","volume":"46","author":"Knauf","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib564","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00005344-199509000-00008","article-title":"Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure","volume":"26","author":"Knauf","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib565","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfh650","article-title":"A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension","volume":"20","author":"Dussol","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 7","key":"10.1111\/j.1600-6143.2009.02834.x_bib566","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-6135.2004.0355.x","article-title":"Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib567","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib568","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib569","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib570","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1542\/peds.2006-1812","article-title":"Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement","volume":"120","year":"2007","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib571","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.CIR.95.6.1646","article-title":"National Cholesterol Education Program recommendations for cholesterol testing in young adults. A science-based approach","volume":"95","author":"Cleeman","year":"1997","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib572","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/tc.11.1.44","article-title":"WHO Europe evidence based recommendations on the treatment of tobacco dependence","volume":"11","author":"Raw","year":"2002","journal-title":"Tob Control"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib573","unstructured":"Counseling to prevent tobacco use and tobacco-caused disease. In, Rockville, MD, US Preventive Services Task Force. Agency for Healthcare Research and Quality 2003, pp 1\u20135."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib574","unstructured":"VA\/DoD clinical practice guideline for the management of tobacco use. Dept. of Veteran Affairs. In, Washington, DC, 2004, p 81."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib575","unstructured":"Ranney L, Melvin C, Lux L et al. Tobacco use: Prevention, cessation, and control. Evidence Report\/Technology Assessment No.140. (Prepared by the RTI International-University of North Carolina Evidence-Based Practice Center under Contract No. 290\u201302-0016). AHRQ Publication No. 06-E015. In, Rockville, MD, US Preventive Services Task Force, Agency for Healthcare Research and Quality (AHRQ), 2006."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib576","unstructured":"Fiore MC, Jaen CR, Baker TB et al. Clinical practice guideline: Treating tobacco use and dependence: 2008 update. U.S. Department of Health and Human Services, Public Health Service, May 2008. In, Washington, DC, US Department of Health and Human Services. Public Health Service, 2008."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib577","unstructured":"Brief interventions and referral for smoking cessation in primary care and other settings. Public Health Interventions Advisory Committee (PHIAC). Public Health Intervention Guidance no. 1. March, 2006. NHS National Institute for Health and Clinical Excellence (NICE). In, London, England, UK, 2006."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib578","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7326\/0003-4819-150-8-200904210-00009","article-title":"Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib579","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(06)69249-0","article-title":"Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study","volume":"368","author":"Teo","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib580","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-145-11-200612050-00142","article-title":"Systematic review: Smoking cessation intervention strategies for adults and adults in special populations","volume":"145","author":"Ranney","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib581","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/1471-2458-6-300","article-title":"Effectiveness of smoking cessation therapies: A systematic review and meta-analysis","volume":"6","author":"Wu","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib582","doi-asserted-by":"crossref","first-page":"b1024","DOI":"10.1136\/bmj.b1024","article-title":"Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: Systematic review and meta-analysis","volume":"338","author":"Moore","year":"2009","journal-title":"BMJ"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib583","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-142-4-200502150-00005","article-title":"The effects of a smoking cessation intervention on 14. 5-year mortality: A randomized clinical trial","volume":"142","author":"Anthonisen","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib584","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1378\/chest.06-1587","article-title":"Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease","volume":"131","author":"Mohiuddin","year":"2007","journal-title":"Chest"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib585","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/104454601750284117","article-title":"Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate","volume":"11","author":"Lewis","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib586","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1034\/j.1399-0012.1999.130410.x","article-title":"Patient survival after renal transplantation: II. The impact of smoking","volume":"13","author":"Cosio","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib587","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00007890-199807270-00012","article-title":"Successful renal transplantation in American Indians","volume":"66","author":"Kasiske","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib588","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1681\/ASN.V114753","article-title":"Cigarette smoking in renal transplant recipients","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib589","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/ndt\/gfl849","article-title":"Identification of current smokers among renal transplant recipients","volume":"22","author":"Nguyen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib590","unstructured":"National Heart, Lung, and Blood Institute. The practical guide: Identification, evaluation, and treatment of overweight and obesity in adults. U.S. Department of Health and Human Services Public Health Service, National Institutes of Health. In, Bethesda, MD, NIH, 2000."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib591","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.2005-0302","article-title":"US Preventive Services Task Force. Screening and interventions for overweight in children and adolescents: Recommendation statement","volume":"116","year":"2005","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib592","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.97.21.2099","article-title":"American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee","volume":"97","author":"Eckel","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib593","doi-asserted-by":"crossref","first-page":"930","DOI":"10.7326\/0003-4819-139-11-200312020-00012","article-title":"Screening for obesity in adults: Recommendations and rationale","volume":"139","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib594","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/01.CIR.0000145546.97738.1E","volume":"110","author":"Klein","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib595","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1161\/01.CIR.0000161369.71722.10","article-title":"Overweight in children and adolescents: Pathophysiology, consequences, prevention, and treatment","volume":"111","author":"Daniels","year":"2005","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib596","unstructured":"VA\/DoD clinical practice guideline for screening and management of overweight and obesity. Management of Overweight and Obesity Working Group. In, Washington, DC, Department of Veterans Affairs, Department of Defense, 2006, p 117."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib597","unstructured":"Obesity: The prevention, identification, assessment and management of overweight and obesity in adults and children. National Collaborating Centre for Primary Care and the Centre for Public Health Excellence at NICE (NHS National Institute for Health and Clinical Excellence, UK). In, London, England, UK, National Collaborating Centre for Primary Care and the Centre for Public Health Excellence at NICE (NHS National Institute for Health and Clinical Excellence, UK), 2006."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib598","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1399-0012.1996.tb00467.x","article-title":"Gastric bypass in morbidly obese kidney transplant recipients","volume":"10","author":"Marterre","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib599","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.TP.0000128858.84976.27","article-title":"Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant","volume":"78","author":"Alexander","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib600","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/011542650702200116","article-title":"Gastric bypass in chronic renal failure and renal transplant","volume":"22","author":"Alexander","year":"2007","journal-title":"Nutr Clin Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib601","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1051-2276(98)90005-X","article-title":"The effect of dietary intervention on weight gains after renal transplantation","volume":"8","author":"Patel","year":"1998","journal-title":"J Ren Nutr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib602","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0899-9007(98)00137-3","article-title":"Benefits of a dietary intervention on weight loss, body composition, and lipid profile after renal transplantation","volume":"15","author":"Lopes","year":"1999","journal-title":"Nutrition"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib603","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0272-6386(03)00673-5","article-title":"Effects of exercise training on coronary heart disease risk factors in renal transplant recipients","volume":"42","author":"Painter","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib604","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","article-title":"Meta-analysis: Pharmacologic treatment of obesity","volume":"142","author":"Li","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib605","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: The STRADIVARIUS randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib606","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: A meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib607","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4158\/EP.8.2.124","article-title":"Obesity in transplant patients: Case report showing interference of orlistat with absorption of cyclosporine and review of literature","volume":"8","author":"Barbaro","year":"2002","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib608","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0041-1345(01)02829-9","article-title":"Reduction in blood cyclosporine concentration by orlistat in two renal transplant patients","volume":"34","author":"Errasti","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib609","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/ajkd.2003.50061","article-title":"Drug interaction in a renal transplant patient: Cyclosporin-neoral and orlistat","volume":"41","author":"Evans","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib610","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: A systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib611","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-142-7-200504050-00013","article-title":"Meta-analysis: Surgical treatment of obesity","volume":"142","author":"Maggard","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib612","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib613","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib614","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.transproceed.2006.08.092","article-title":"Complications of laparoscopic gastric banding in renal transplant recipients: A case study","volume":"38","author":"Buch","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib615","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ehj.2003.10.013","article-title":"Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology","volume":"25","author":"Patrono","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib616","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib617","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.107.181546","article-title":"Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update","volume":"115","author":"Mosca","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib618","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00129784-200404030-00001","article-title":"Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention","volume":"4","author":"Irish","year":"2004","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib619","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1097\/01.TP.0000129407.31494.45","article-title":"Low-dose aspirin therapy is associated with improved allograft function and prolonged allograft survival after kidney transplantation","volume":"77","author":"Grotz","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib620","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib621","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib622","unstructured":"GLOBOCAN 2002. In, International Agency for Research on Cancer, Cancer Mondial, 2002."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib623","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib624","unstructured":"United States Cancer Statistics: 1999\u20132005 incidence and mortality web-based report. U.S. Cancer Statistics Working Group, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. In (vol 2009), Atlanta, GA, U.S. Cancer Statistics Working Group, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2009."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib625","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1600-6143.2007.01908.x","article-title":"Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: A cohort study of 15,183 recipients","volume":"7","author":"Webster","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib626","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/ajkd.2003.50130","article-title":"Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: A prospective study in Queensland, Australia","volume":"41","author":"Carroll","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 15","key":"10.1111\/j.1600-6143.2009.02834.x_bib627","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib628","unstructured":"Helfand M, Krages KP: Counseling to prevent skin cancer: A summary of the evidence. In, US Preventive Services Task Force, Agency for Healthcare Research and Quality (AHRQ), 2003, p 253."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib629","first-page":"422","article-title":"Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation: A systematic review","volume":"27","author":"Saraiya","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib630","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","article-title":"Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: A randomised controlled trial","volume":"354","author":"Green","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib631","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jama.279.18.1426-JMN0513-3-1","article-title":"Dermatologists call for massive cover-up","volume":"279","author":"Lamberg","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib632","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jnci\/88.1.17","article-title":"Screening for cutaneous melanoma by skin self-examination","volume":"88","author":"Berwick","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib633","first-page":"31","article-title":"European best practice guidelines for renal transplantation Section IV: Long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: Prevention and treatment","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib634","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jms.5.3.156","article-title":"General practitioner screening for melanoma: Sensitivity, specificity, and effect of training","volume":"5","author":"Burton","year":"1998","journal-title":"J Med Screen"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib635","first-page":"97, 99","article-title":"U.S. Preventive Services Task Force Screening for skin cancer: Recommendations and rationale","volume":"102","year":"2002","journal-title":"Am J Nurs"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib636","first-page":"232","article-title":"Skin cancer prevention and screening: Summary of the American College of Preventive Medicine\u2019s practice policy statements","volume":"48","author":"Hill","year":"1998","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib637","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0190-9622(99)70149-0","article-title":"Awareness of skin cancer by kidney transplant patients","volume":"40","author":"Cowen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib638","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ijc.21455","article-title":"Increase in skin cancer screening during a community-based randomized intervention trial","volume":"118","author":"Aitken","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib639","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archfami.8.2.170","article-title":"Comparison of dermatologic diagnoses by primary care practitioners and dermatologists. A review of the literature","volume":"8","author":"Federman","year":"1999","journal-title":"Arch Fam Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib640","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5694\/j.1326-5377.2007.tb01202.x","article-title":"Diagnosing skin cancer in primary care: How do mainstream general practitioners compare with primary care skin cancer clinic doctors?","volume":"187","author":"Youl","year":"2007","journal-title":"Med J Aust"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib641","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib642","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2005.06347.x","article-title":"Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: A systematic review of randomized controlled trials","volume":"152","author":"Chen","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib643","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1001\/jama.281.21.2029","article-title":"Users\u2019 guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group","volume":"281","author":"Barratt","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib644","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.285.21.2750","article-title":"Cancer screening in elderly patients: A framework for individualized decision making","volume":"285","author":"Walter","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib645","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/jnci\/94.19.1469","article-title":"Costs and benefits of different strategies to screen for cervical cancer in less-developed countries","volume":"94","author":"Mandelblatt","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib646","first-page":"127","article-title":"Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy","volume":"20","author":"Ozsaran","year":"1999","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib647","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.298.6667.153","article-title":"Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts","volume":"298","author":"Alloub","year":"1989","journal-title":"BMJ"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib648","first-page":"417","article-title":"ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995)","volume":"102","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib649","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/TP.0b013e31819d32eb","article-title":"The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients","volume":"87","author":"Wong","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib650","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMp078053","article-title":"Introducing HPV vaccine in developing countries-key challenges and issues","volume":"356","author":"Agosti","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib651","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib652","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0140-6736(90)90066-E","article-title":"Edinburgh trial of screening for breast cancer: Mortality at seven years","volume":"335","author":"Roberts","year":"1990","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib653","first-page":"CD001877","article-title":"Screening for breast cancer with mammography","author":"Gotzsche","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib654","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1034\/j.1600-6143.2003.00118.x","article-title":"Screening for prostate, breast and colorectal cancer in renal transplant recipients","volume":"3","author":"Kiberd","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib655","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/1097-0142(19880801)62:3<645::AID-CNCR2820620333>3.0.CO;2-#","article-title":"Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subJects","volume":"62","author":"Kewenter","year":"1988","journal-title":"Cancer"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib656","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(96)03430-7","article-title":"Randomised study of screening for colorectal cancer with faecal-occult-blood test","volume":"348","author":"Kronborg","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib657","unstructured":"Australian Cancer Network Colorectal Cancer Guidelines Revision Committee. Guidelines for the prevention, early detection and management of colorectal cancer. The Cancer Council Australia and Australian Cancer Network, Sydney. Chapter 3: Population screening for colorectal cancer. In, Sydney, Australia, Australian Government National Health and Medical Research Council, 2005, pp. 32\u201345."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib658","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(96)03386-7","article-title":"Randomised controlled trial of faecal-occult-blood screening for colorectal cancer","volume":"348","author":"Hardcastle","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib659","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/TP.0b013e3181639d35","article-title":"Cost-effectiveness of colorectal cancer screening in renal transplant recipients","volume":"85","author":"Wong","year":"2008","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1111\/j.1600-6143.2009.02834.x_bib660","first-page":"iii1","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults","volume":"52","author":"Ryder","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib661","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jnci\/83.13.916","article-title":"Workshop on screening for hepatocellular carcinoma","volume":"83","author":"McMahon","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib662","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/00004836-200211002-00004","article-title":"Screening for hepatocellular carcinoma","volume":"35","author":"Nguyen","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib663","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1572-0241.2006.00467.x","article-title":"Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: A systematic review","volume":"101","author":"Colli","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib664","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/j.1572-0241.1999.01297.x","article-title":"Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: Results of a national survey","volume":"94","author":"Chalasani","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib665","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MCG.0b013e3180381560","article-title":"Utilization of screening for hepatocellular carcinoma in the United States","volume":"41","author":"Davila","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib666","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/jlts.2003.50139","article-title":"Screening for hepatocellular carcinoma: Is it cost-effective?","volume":"9","author":"Wolf","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib667","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib668","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1258\/096914103771773320","article-title":"Screening for liver cancer: Results of a randomised controlled trial in Qidong, China","volume":"10","author":"Chen","year":"2003","journal-title":"J Med Screen"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib669","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000046265","article-title":"Long-term impact of hepatitis B, C virus infection on renal transplantation","volume":"21","author":"Lee","year":"2001","journal-title":"Am J Nephrol"},{"issue":"Suppl 2S","key":"10.1111\/j.1600-6143.2009.02834.x_bib670","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.tp.0000332545.03377.8e","article-title":"Immunosuppression is a risk factor for urinary tract cancers in renal transplant recipients","volume":"86","author":"Goh","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib671","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2215\/CJN.03661106","article-title":"Renal cell carcinoma in transplant recipients with acquired cystic kidney disease","volume":"2","author":"Schwarz","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib672","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.transproceed.2006.06.021","article-title":"Kidney ultrasound is useful tool in posttransplant follow-up","volume":"38","author":"Chiang","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib673","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.1995.286","article-title":"Screening for acquired cystic kidney disease: A decision analytic perspective","volume":"48","author":"Sarasin","year":"1995","journal-title":"Kidney Int"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib674","first-page":"31","article-title":"European best practice guidelines for renal transplantation Section IV: Long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): Prevention and treatment","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib675","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"issue":"Suppl 2S","key":"10.1111\/j.1600-6143.2009.02834.x_bib676","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.tp.0000332547.88129.b9","article-title":"Currency of receipt of immunosuppressive agents and other risk factors for lip cancer following renal transplantation","volume":"86","author":"Van Leeuwen","year":"2008","journal-title":"Transplantation"},{"issue":"Suppl 2S","key":"10.1111\/j.1600-6143.2009.02834.x_bib677","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.tp.0000331934.97193.4e","article-title":"Risk for non-Hodgkin lymphoma following renal transplantation is associated with currency of receipt of immunosuppression and reverts to normal on cessation","volume":"86","author":"Van Leeuwen","year":"2008","journal-title":"Transplantation"},{"issue":"Suppl 2S","key":"10.1111\/j.1600-6143.2009.02834.x_bib678","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.tp.0000331938.42935.c5","article-title":"Rates of human papillomavirus (HPV)-related cancers are increased in renal transplant recipients and return to low levels on cessation of immune suppression","volume":"86","author":"Grulich","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib679","first-page":"459","article-title":"Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants","volume":"137","author":"Otley","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib680","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib681","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181761659","article-title":"Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder","volume":"86","author":"Swinnen","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib682","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib683","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/ndt\/gfm089","article-title":"Kaposi\u2019s sarcoma in renal transplant recipients-the impact of proliferation signal inhibitors","volume":"22","author":"Campistol","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib684","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/17.5.892","article-title":"Successful treatment of post-transplant Kaposi\u2019s sarcoma by reduction of immunosuppression","volume":"17","author":"Duman","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 113","key":"10.1111\/j.1600-6143.2009.02834.x_bib684a","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib685","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib686","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01510506","article-title":"Bone disease after renal transplantation","volume":"1","author":"Weisinger","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib687","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","article-title":"High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation","volume":"11","author":"Monier-Faugere","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib688","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/ndt\/gfh303","article-title":"Natural history of vascular calcification in dialysis and transplant patients","volume":"19","author":"Moe","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib689","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","article-title":"Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure","volume":"21","author":"Egbuna","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib690","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1111\/j.1600-6143.2007.01978.x","article-title":"Vitamin D status in renal transplant recipients","volume":"7","author":"Stavroulopoulos","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib691","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.tp.0000287430.19960.0e","article-title":"Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft","volume":"84","author":"Yakupoglu","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib692","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1432-2277.2006.00436.x","article-title":"Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients","volume":"20","author":"Schaeffner","year":"2007","journal-title":"Transpl Int"},{"issue":"Suppl 3","key":"10.1111\/j.1600-6143.2009.02834.x_bib693","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/ndt\/13.suppl_3.94","article-title":"Parathyroid function in long-term renal transplant patients: Importance of pre-transplant PTH concentrations","volume":"13","author":"Torres","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib694","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1093\/ndt\/12.11.2393","article-title":"Parathyroidectomy after renal transplantation: A retrospective analysis of long-term outcome","volume":"12","author":"Schmid","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib695","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1034\/j.1399-0012.2003.00047.x","article-title":"Hyperparathyroidism and long-term bone loss after renal transplantation","volume":"17","author":"Heaf","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib696","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0272-6386(97)90129-3","article-title":"No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients","volume":"29","author":"Dumoulin","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib697","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1600-6143.2008.02423.x","article-title":"Can DXA predict fractures in renal transplant patients?","volume":"8","author":"Akaberi","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib698","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1097\/01.ASN.0000016082.70875.36","article-title":"Treatment with vitamin D and calcium reduces bone loss after renal transplantation: A randomized study","volume":"13","author":"De Sevaux","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib699","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1523-1755.2004.00432.x","article-title":"Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation","volume":"65","author":"Torres","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib700","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.TP.0000137937.44703.42","article-title":"Calcium and calcitriol prophylaxis attenuates posttransplant bone loss","volume":"78","author":"Josephson","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib701","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1097\/01.ASN.0000087092.53894.80","article-title":"Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate","volume":"14","author":"Coco","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib702","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1681\/ASN.V1271530","article-title":"Effect of ibandronate on bone loss and renal function after kidney transplantation","volume":"12","author":"Grotz","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib703","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0272-6386(00)70331-3","article-title":"Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation","volume":"35","author":"Cueto-Manzano","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib704","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000092523.30277.13","article-title":"Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate","volume":"76","author":"Jeffery","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib705","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-3046.2004.00191.x","article-title":"Treatment of osteopenia and osteoporosis in renal transplant children and adolescents","volume":"8","author":"El-Husseini","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib706","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/j.1600-6143.2004.00618.x","article-title":"A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents","volume":"4","author":"El-Husseini","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib707","first-page":"S1","article-title":"National Kidney Foundation KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib708","first-page":"49","article-title":"European best practice guidelines for renal transplantation Section IV: Long-term management of the transplant recipient. IV.9.2. Haematological complications. Leukopenia","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib709","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80153-3","article-title":"Posttransplant erythrocytosis: An enigma revisited","volume":"24","author":"Gaston","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib710","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2003.00850.x","article-title":"Posttransplant erythrocytosis","volume":"63","author":"Vlahakos","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib711","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/oxfordjournals.ndt.a027674","article-title":"Recombinant human erythropoietin corrects anaemia during the first weeks after renal transplantation: A randomized prospective study","volume":"11","author":"Van Loo","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib712","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/j.ajkd.2006.11.034","article-title":"Anemia after kidney transplantation is not completely explained by reduced kidney function","volume":"49","author":"Chadban","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib713","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-0012.1994.tb00377.x","article-title":"Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients","volume":"8","author":"Moore","year":"1994","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib714","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM198310063091401","article-title":"A randomized clinical trial of cyclosporine in cadaveric renal transplantation","volume":"309","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib715","first-page":"986","article-title":"Cyclosporin in cadaveric renal transplantation One-year follow-up of a multicentre trial","volume":"2","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib716","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-6143.2003.00133.x","article-title":"Prevalence and management of anemia in renal transplant recipients: A European survey","volume":"3","author":"Vanrenterghem","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib717","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/ndt\/11.7.1371","article-title":"Azathioprine-induced pure red-cell aplasia","volume":"11","author":"PruiJt","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib718","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute reJection. European Mycophenolate Mofetil Cooperative Study Group","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib719","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5414\/CNP60119","article-title":"Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients","volume":"60","author":"Engelen","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib720","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1432-2277.2007.00523.x","article-title":"Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation","volume":"20","author":"Faguer","year":"2007","journal-title":"Transpl Int"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib721","first-page":"48","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.1. Haematological complications. Anaemia","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib722","first-page":"28","article-title":"Thrombotic microangiopathy in renal transplantation","volume":"7","author":"Chiurchiu","year":"2002","journal-title":"Ann Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib723","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5414\/CNP67335","article-title":"De novo thrombotic microangiopathy. An underrated complication of renal transplantation","volume":"67","author":"Ponticelli","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib724","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib725","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/archinte.163.16.1975","article-title":"Trimethoprim-sulfamethoxazole-induced life-threatening agranulocytosis","volume":"163","author":"Andres","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib726","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/01.tp.0000184275.81396.45","article-title":"Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation","volume":"80","author":"Mitsuhata","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib727","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-200108150-00041","article-title":"Neutropenia after treatment of posttransplantation erythrocytosis with enalapril","volume":"72","author":"Donadio","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib728","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: Agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib729","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00007890-199806150-00007","article-title":"A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: Results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group","volume":"65","author":"Mathew","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib730","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1093\/oxfordjournals.ndt.a027192","article-title":"Severe thrombocytopenia with OKT3 use for steroid-resistant reJection in a cadaveric renal transplant recipient","volume":"11","author":"Mackie","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib731","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00007890-200209270-00026","article-title":"TTP\/HUS occurring in a simultaneous pancreas\/kidney transplant recipient after clopidogrel treatment: Evidence of a nonimmunological etiology","volume":"74","author":"Evens","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib732","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1600-6143.2005.00828.x","article-title":"Heparin-induced thrombocytopenia in a renal transplant recipient","volume":"5","author":"Anderegg","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib733","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1681\/ASN.2006010027","article-title":"Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: Risk factors and implications for mortality","volume":"17","author":"Imoagene-OyedeJi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib734","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1600-6143.2006.01727.x","article-title":"Anemia is associated with mortality in kidney-transplanted patients-a prospective cohort study","volume":"7","author":"Molnar","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib735","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/ndt\/gfl457","article-title":"A prospective study of anaemia and long-term outcomes in kidney transplant recipients","volume":"21","author":"Winkelmayer","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib736","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.TP.0000150370.51700.99","article-title":"Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation","volume":"79","author":"Van Biesen","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib737","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00007890-200101150-00013","article-title":"The use of pretransplant erythropoietin to normalize hemoglobin levels has no deleterious effects on renal transplantation outcome","volume":"71","author":"Linde","year":"2001","journal-title":"Transplantation"},{"issue":"Suppl 5","key":"10.1111\/j.1600-6143.2009.02834.x_bib738","first-page":"1","article-title":"European best practice guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure","volume":"14","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib739","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-1755.2000.00816.x","article-title":"Long-term survival in renal transplant recipients with graft function","volume":"57","author":"OJo","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib740","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"2000 update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel","volume":"18","author":"Ozer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib741","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute reJection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib742","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib743","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1399-0012.2003.00052.x","article-title":"A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil","volume":"17","author":"Royer","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib744","first-page":"11","article-title":"A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine","volume":"119","author":"Maki","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib745","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/clinids\/4.2.614","article-title":"A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients","volume":"4","author":"Tolkoff-Rubin","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib746","first-page":"267","article-title":"Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: Ciprofloxacin versus co-trimoxazole","volume":"15","author":"Imrie","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib747","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.transproceed.2007.02.014","article-title":"Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection","volume":"39","author":"Razeghi","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib748","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: A review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib749","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0272-6386(00)70210-1","article-title":"Thrombocytopenia after kidney transplantation","volume":"35","author":"Nuesch","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib750","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/ndt\/17.6.1119","article-title":"Prednisone-induced neutropenia after cadaveric kidney transplantation","volume":"17","author":"Schaub","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib751","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/ncpneph0609","article-title":"Parvovirus-B19-associated complications in renal transplant recipients","volume":"3","author":"Waldman","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib752","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","article-title":"Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation","volume":"11","author":"Murer","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib753","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2796.1990.tb00195.x","article-title":"Azathioprine and allopurinol: A potentially dangerous combination","volume":"228","author":"Venkat Raman","year":"1990","journal-title":"J Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib754","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1056\/NEJM199911113412004","article-title":"Alloimmune thrombocytopenia after organ transplantation","volume":"341","author":"West","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib755","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-6143.2004.00679.x","article-title":"Disseminated intravascular coagulation (DIC) in a kidney donor associated with transient recipient DIC","volume":"5","author":"Bennett","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib756","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s004670050393","article-title":"Treatment of neutropenia in a renal transplant recipient with granulocyte colony-stimulating factor","volume":"12","author":"Moghal","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib757","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-0012.1996.tb00638.x","article-title":"Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients","volume":"10","author":"Peddi","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib758","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/ndt\/10.11.2166","article-title":"Worsening of renal function in a renal transplant patient treated with granulocyte colony-stimulating factor","volume":"10","author":"Minguez","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib759","first-page":"48","article-title":"European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.9.3. Haematological complications","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib760","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2001.19.5.1519","article-title":"Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology","volume":"19","author":"Schiffer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib761","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/j.transproceed.2005.08.041","article-title":"Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients","volume":"37","author":"Akcay","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib762","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.transproceed.2005.08.023","article-title":"Erythrocytosis after renal transplantation: Review of 101 cases","volume":"37","author":"Einollahi","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib763","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1034\/j.1600-6143.2003.00131.x","article-title":"Post transplant erythrocytosis in hypercalcemic renal transplant recipients","volume":"3","author":"Kurella","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib764","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/S0041-1345(02)03673-4","article-title":"Postrenal transplant erythrocytosis: Risk factors and effectiveness of angiotensin receptor antagonists","volume":"34","author":"Singh","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib765","first-page":"57","article-title":"Ramipril in post-renal transplant erythrocytosis","volume":"20","author":"Esposito","year":"2007","journal-title":"J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib766","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1987.241","article-title":"Dynamics of erythropoiesis following renal transplantation","volume":"32","author":"Besarab","year":"1987","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib767","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ki.1983.86","article-title":"Postrenal transplant erythrocytosis: A review of 53 patients","volume":"23","author":"Wickre","year":"1983","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib768","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002480-199339010-00012","article-title":"Erythrocytosis after renal transplantation. A prospective analysis","volume":"39","author":"Sumrani","year":"1993","journal-title":"ASAIO J"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib769","first-page":"83","article-title":"Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study","volume":"45","author":"Kessler","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib770","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.1991.328","article-title":"Factors predictive of post-transplant erythrocytosis","volume":"40","author":"Qunibi","year":"1991","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib771","first-page":"948","article-title":"Erythrocytosis and thromboembolic complications after renal transplantation: Results from a randomized trial of cyclosporine versus azathioprine-antilymphocyte globulin","volume":"20","author":"Gruber","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib772","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02549838","article-title":"Haematological changes after renal transplantation: Differences between cyclosporin-A and azathioprine therapy","volume":"22","author":"Fang","year":"1990","journal-title":"Int Urol Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib773","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/00007890-199804270-00023","article-title":"Incidence of posttransplant erythrocytosis (PTE) in kidney graft recipients where the recipient of the contralateral kidney developed PTE","volume":"65","author":"Klaassen","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib774","first-page":"119","article-title":"Erythrocythemia following renal transplantation: Influence of diuretic therapy","volume":"29","author":"Pollak","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib775","first-page":"2141","article-title":"No association between post-transplant erythrocytosis, thromboembolic events, and cyclosporine therapy","volume":"21","author":"Glicklich","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib776","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archinte.1980.00330140139040","article-title":"Polycythemia in renal transplant patients","volume":"140","author":"Kay","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib777","first-page":"399","article-title":"Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis","volume":"16","author":"Yildiz","year":"2003","journal-title":"J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib778","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000167467","article-title":"Polycythaemia following renal transplantation: An association with azathioprine dosage?","volume":"7","author":"Webb","year":"1987","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib779","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PPO.0b013e3181594774","article-title":"Expertise-based management in essential thrombocythemia and polycythemia vera","volume":"13","author":"Finazzi","year":"2007","journal-title":"Cancer J"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib780","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/sonc.2002.33756","article-title":"The risk of thrombosis in essential thrombocythemia and polycythemia vera","volume":"29","author":"Pearson","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib781","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib782","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.297.22.2481","article-title":"Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery","volume":"297","author":"Wu","year":"2007","journal-title":"JAMA"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib783","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano","year":"2008","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib784","first-page":"474","article-title":"[Thromboembolism risk factors in kidney transplant patients with secondary erythrocytosis in relation to hemorheologic aspects]","volume":"43","author":"Koall","year":"1988","journal-title":"Z Gesamte Inn Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib785","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00007890-199507270-00004","article-title":"Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism","volume":"60","author":"Danovitch","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib786","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/ndt\/12.12.2683","article-title":"Effect of losartan on haemoglobin concentration in renal transplant recipients-a retrospective analysis","volume":"12","author":"Ducloux","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib787","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1681\/ASN.V961104","article-title":"Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis","volume":"9","author":"Julian","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib788","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/ndt\/10.12.2316","article-title":"A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation","volume":"10","author":"Beckingham","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib789","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/039139889501800104","article-title":"Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients","volume":"18","author":"Lal","year":"1995","journal-title":"Int J Artif Organs"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib790","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000189445","article-title":"Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors","volume":"74","author":"MacGregor","year":"1996","journal-title":"Nephron"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib791","first-page":"47","article-title":"Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: Efficacy, safety and action mechanisms","volume":"53","author":"Montanaro","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib792","first-page":"145","article-title":"[Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors]","volume":"54","author":"Morale","year":"2002","journal-title":"Minerva Urol Nefrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib793","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000168856","article-title":"Association of post-renal transplant erythrocytosis and microalbuminuria: Response to angiotensin-converting enzyme inhibition","volume":"15","author":"Mulhern","year":"1995","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib794","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0272-6386(95)90496-4","article-title":"Enalapril treatment of posttransplant erythrocytosis: Efficacy independent of circulating erythropoietin levels","volume":"26","author":"Perazella","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib795","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/00007890-199404150-00013","article-title":"Correction of posttransplant erythrocytosis with enalapril","volume":"57","author":"Rell","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib796","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007890-200108150-00035","article-title":"Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: Prospective randomized study","volume":"72","author":"Yildiz","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib797","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00007890-199709150-00023","article-title":"Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis","volume":"64","author":"Klaassen","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib798","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199007123230203","article-title":"Effects of theophylline on erythropoietin production in normal subJects and in patients with erythrocytosis after renal transplantation","volume":"323","author":"Bakris","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib799","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000188539","article-title":"Theophylline modulates erythrocytosis after renal transplantation","volume":"70","author":"Grekas","year":"1995","journal-title":"Nephron"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib800","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/00007890-199806150-00009","article-title":"Use of aminophylline and enalapril in posttransplant polycythemia","volume":"65","author":"Mazzali","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib801","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/00007890-199506000-00021","article-title":"Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation","volume":"59","author":"Ok","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib802","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/JDI-120017470","article-title":"A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis","volume":"25","author":"Trivedi","year":"2003","journal-title":"Ren Fail"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib803","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/tri.1992.5.s1.35","article-title":"Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporin. Leuven Collaborative Group for Transplantation","volume":"5","author":"Vanrenterghem","year":"1992","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib804","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib805","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib806","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1681\/ASN.V115974","article-title":"Renal transplant-associated hyperuricemia and gout","volume":"11","author":"Clive","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib807","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semnephrol.2004.09.008","article-title":"Uric acid and transplantation","volume":"25","author":"Mazzali","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib808","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.tp.0000188722.84775.af","article-title":"New-onset gout after kidney transplantation: Incidence, risk factors and implications","volume":"80","author":"Abbott","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib809","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198908033210504","article-title":"Cyclosporine-induced hyperuricemia and gout","volume":"321","author":"Lin","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib810","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0272-6386(87)80103-8","article-title":"The incidence of gout in renal transplant recipients","volume":"10","author":"West","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib811","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9610(88)80196-X","article-title":"Hyperuricemia after renal transplantation","volume":"156","author":"Gores","year":"1988","journal-title":"Am J Surg"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib812","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1440-1797.2006.00577.x","article-title":"Gout in renal transplant recipients","volume":"11","author":"Stamp","year":"2006","journal-title":"Nephrology (Carlton)"},{"issue":"Suppl 12","key":"10.1111\/j.1600-6143.2009.02834.x_bib813","first-page":"186","article-title":"Levels and progression of parameters associated with metabolic syndrome by immunosuppressive regimen: Evidence from the Symphony Study. Abstract #155 (ORAL)","volume":"7","author":"Vanrenterhem","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib814","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1016\/j.transproceed.2005.08.042","article-title":"Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients","volume":"37","author":"Kanbay","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib815","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/ndt\/gfh957","article-title":"Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus","volume":"20","author":"Bumbea","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib816","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(00)04055-1","article-title":"Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: A randomised controlled study","volume":"357","author":"Schlitt","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib817","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00858973","article-title":"Natural history and etiology of hyperuricemia following pediatric renal transplantation","volume":"9","author":"Edvardsson","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib818","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1681\/ASN.2005010063","article-title":"Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link?","volume":"16","author":"Johnson","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib819","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1440-1797.2004.00336.x","article-title":"Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed","volume":"9","author":"Kanellis","year":"2004","journal-title":"Nephrology (Carlton)"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib820","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000186160","article-title":"Acute hyperuricemic nephropathy and renal failure after transplantation","volume":"56","author":"Venkataseshan","year":"1990","journal-title":"Nephron"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib821","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"Suppl S1","key":"10.1111\/j.1600-6143.2009.02834.x_bib822","first-page":"25","article-title":"Uric acid","volume":"11","author":"Johnson","year":"2006","journal-title":"Nephrology"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib823","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00007890-200108270-00019","article-title":"Uricosuric effect of losartan in patients with renal transplants","volume":"72","author":"Kamper","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib824","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib825","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00007890-198810000-00030","article-title":"Nonsteroidal antiinflammatory drugs and cyclosporine. A potentially serious adverse interaction","volume":"46","author":"Harris","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib826","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1592\/phco.25.5.773.63585","article-title":"Celecoxib-induced nephrotoxicity in a renal transplant recipient","volume":"25","author":"Clifford","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib827","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-133-5-200009050-00024","article-title":"Acute renal failure associated with rofecoxib","volume":"133","author":"Wolf","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib828","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/ndt\/11.10.2055","article-title":"Colchicine toxicity in patients with chronic renal failure","volume":"11","author":"Montseny","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib829","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1432-2277.2002.tb00181.x","article-title":"Colchicine myoneuropathy in a renal transplant patient","volume":"15","author":"Dupont","year":"2002","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib830","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","article-title":"Colchicine myopathy and neuropathy","volume":"316","author":"Kuncl","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib831","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00007890-199710150-00027","article-title":"Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout","volume":"64","author":"Jacobs","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib832","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ndt\/18.3.603","article-title":"Long-term efficacy of hyperuricaemia treatment in renal transplant patients","volume":"18","author":"Perez-Ruiz","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib833","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jbspin.2004.07.006","article-title":"Current management of gout in patients unresponsive or allergic to allopurinol","volume":"71","author":"Bardin","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib834","first-page":"359","article-title":"Pubertal growth and final height in chronic renal failure. In: Sch\u00e4rer K (ed). Growth and endocrine changes in children and adolescents with chronic renal failure S.","author":"Schaefer","year":"1989","journal-title":"Karger AG, Basel: Heidelburg, Germany"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib835","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1203\/00006450-199409000-00009","article-title":"Final height and its predictive factors after renal transplantation in childhood","volume":"36","author":"Hokken-Koelega","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib836","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1067\/mpd.2001.117582","article-title":"Growth hormone treatment in children with chronic renal failure: A meta-analysis of randomized controlled trials","volume":"139","author":"Vimalachandra","year":"2001","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib837","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00866726","article-title":"Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Genentech Collaborative Study Group","volume":"9","author":"Fine","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib838","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM200009283431304","article-title":"Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure","volume":"343","author":"Haffner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib839","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/adc.79.6.481","article-title":"Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology","volume":"79","author":"Maxwell","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib840","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3476(98)70283-5","article-title":"Catch-up growth occurs after renal transplantation in children of pubertal age","volume":"133","author":"Maxwell","year":"1998","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib841","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00467-004-1688-5","article-title":"Long-term use of recombinant human growth hormone in pediatric allograft recipients: A report of the NAPRTCS Transplant Registry","volume":"20","author":"Fine","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib842","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1397-3142.2003.00113.x","article-title":"Hodgkin\u2019s lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient","volume":"8","author":"Dharnidharka","year":"2004","journal-title":"Pediatr Transplant"},{"issue":"Suppl 53","key":"10.1111\/j.1600-6143.2009.02834.x_bib843","first-page":"S128","article-title":"A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant","author":"Hokken-Koelega","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib844","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s004670050483","article-title":"Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology","volume":"12","author":"Guest","year":"1998","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib845","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1523-1755.2002.00489.x","article-title":"Recombinant human growth hormone post-renal transplantation in children: A randomized controlled study of the NAPRTCS","volume":"62","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib846","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00467-002-0962-7","article-title":"Does growth hormone treatment affect the risk of post-transplant renal cancer?","volume":"17","author":"Mehls","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib847","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0022-3476(68)80176-3","article-title":"Extended hemodialysis in children with chronic renal failure","volume":"73","author":"Fine","year":"1968","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib848","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0022-3476(70)80473-5","article-title":"Renal homotransplantation in children","volume":"76","author":"Fine","year":"1970","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib849","first-page":"79","article-title":"Alternate-day steroids in children after renal transplantation","volume":"7","author":"Potter","year":"1975","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib850","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3476(05)80234-3","article-title":"Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation","volume":"120","author":"Broyer","year":"1992","journal-title":"J Pediatr"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib851","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00007890-199601150-00008","article-title":"Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study","volume":"61","author":"Jabs","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib852","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-200107150-00006","article-title":"Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation","volume":"72","author":"Sarwal","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib853","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.TP.0000092950.54184.67","article-title":"Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation","volume":"76","author":"Sarwal","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl S2","key":"10.1111\/j.1600-6143.2009.02834.x_bib854","first-page":"192","article-title":"One year results of a prospective, randomized, multicenter trial of steroid avoidance in pediatric renal transplantation","volume":"8","author":"Sarwal","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib855","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0272-6386(00)70254-X","article-title":"Sexual dysfunction after renal replacement therapy","volume":"35","author":"Diemont","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib856","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.V1061381","article-title":"Sexual dysfunction in uremia","volume":"10","author":"Palmer","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib857","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/jarr.2003.50003","article-title":"Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease","volume":"10","author":"Palmer","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib858","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/ndt\/12.12.2654","article-title":"Chronic renal failure and sexual functioning: Clinical status versus obJectively assessed sexual response","volume":"12","author":"Toorians","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib859","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/S0041-1345(99)00757-5","article-title":"Postrenal transplant improvement of sexual function","volume":"31","author":"Ghahramani","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib860","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/01485010290099381","article-title":"Effect of renal transplantation on sexual function","volume":"48","author":"TsuJimura","year":"2002","journal-title":"Arch Androl"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib861","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/hsw\/28.4.264","article-title":"Sexual functioning following renal transplantation","volume":"28","author":"Raiz","year":"2003","journal-title":"Health Soc Work"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib862","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.transproceed.2005.08.067","article-title":"Erectile function in end-stage renal disease before and after renal transplantation","volume":"37","author":"Shamsa","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib863","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.transproceed.2007.03.038","article-title":"Does renal transplantation improve erectile dysfunction in hemodialysed patients? What is the role of associated factors?","volume":"39","author":"Pourmand","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib864","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.transproceed.2005.03.026","article-title":"Sildenafil citrate treatment for erectile dysfunction after kidney transplantation","volume":"37","author":"Zhang","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib865","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.ijir.3901222","article-title":"Critical evaluation of the factors influencing erectile function after renal transplantation","volume":"16","author":"El-Bahnasawy","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib866","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.transproceed.2008.03.037","article-title":"Sexual dysfunction after simultaneous pancreas-kidney transplantation","volume":"40","author":"Jurgensen","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib867","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.transproceed.2006.02.076","article-title":"Efficacy and safety of vardenafil in renal transplant recipients with erectile dysfunction","volume":"38","author":"Demir","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib868","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.ajkd.2006.04.061","article-title":"Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: A randomized, double-blind, placebo-controlled, crossover trial","volume":"48","author":"Sharma","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib869","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib870","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/j.ackd.2007.01.005","article-title":"Management of the pregnant chronic dialysis patient","volume":"14","author":"Reddy","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib871","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0272-6386(12)81116-4","article-title":"Dialysis, transplantation, and pregnancy","volume":"17","author":"Davison","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib872","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/TP.0b013e318170f8ed","article-title":"The experience of pregnancy after renal transplantation: Pregnancies even within postoperative 1 year may be tolerable","volume":"85","author":"Kim","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib873","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/01.tp.0000263357.44975.d0","article-title":"Pregnancy after organ transplantation: A report from the UK Transplant pregnancy registry","volume":"83","author":"Sibanda","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib874","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/oxfordjournals.ndt.a092129","article-title":"Successful pregnancies in women on renal replacement therapy: Report from the EDTA Registry","volume":"7","author":"Rizzoni","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib875","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0272-6386(12)70127-0","article-title":"Effect of pregnancy on long-term function of renal allografts","volume":"19","author":"Sturgiss","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib876","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.tp.0000166912.60006.3d","article-title":"Pregnancy in renal transplant recipients: Long-term effect on patient and graft survival. A single-center experience","volume":"81","author":"Rahamimov","year":"2006","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2009.02834.x_bib877","first-page":"S98","article-title":"The CARI guidelines. Calcineurin inhibitors in renal transplantation: Pregnancy, lactation and calcineurin inhibitors","volume":"12","author":"Grimer","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib878","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.ajkd.2007.03.022","article-title":"Pregnancy in CKD stages 3 to 5: Fetal and maternal outcomes","volume":"49","author":"Imbasciati","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib879","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1600-6143.2005.00969.x","article-title":"Reproduction and transplantation: Report on the AST Consensus Conference on Reproductive Issues and Transplantation","volume":"5","author":"McKay","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib880","first-page":"199","article-title":"Women who become pregnant in the first two years after kidney transplantation have a higher risk of graft loss. Abstract 76","volume":"8","author":"Zalunardo","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib881","first-page":"103","article-title":"Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation","author":"Armenti","year":"2004","journal-title":"Clin Transpl"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib882","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMra050431","article-title":"Pregnancy in recipients of solid organs-effects on mother and child","volume":"354","author":"McKay","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib883","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/00007890-200104150-00028","article-title":"Kidney transplantation during the first trimester of pregnancy: Immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone","volume":"71","author":"Pergola","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib884","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/01.AOG.0000124986.32858.ba","article-title":"Mycophenolate mofetil in pregnancy after renal transplantation: A case of maJor fetal malformations","volume":"103","author":"Le Ray","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib885","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"10.1111\/j.1600-6143.2009.02834.x_bib886","first-page":"1","article-title":"European best practice guidelines for renal transplantation Section IV: Long-term management of the transplant recipient","volume":"17","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib887","unstructured":"Rapamune package insert. 2003."},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib888","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.transproceed.2004.11.102","article-title":"Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient","volume":"36","author":"Jankowska","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib889","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.tp.0000188947.56244.7d","article-title":"Pregnancy under sirolimus-based immunosuppression","volume":"81","author":"Guardia","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib890","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1542\/peds.93.1.137","article-title":"American Academy of Pediatrics Committee on Drugs The transfer of drugs and other chemicals into human milk","volume":"93","year":"1994","journal-title":"Pediatrics"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib891","first-page":"605","article-title":"Breast-feeding after renal transplantation","volume":"14","author":"Coulam","year":"1982","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib892","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJM197706022962201","article-title":"The pituitary-testicular axis in men with chronic renal failure","volume":"296","author":"Holdsworth","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib893","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0022-5347(17)38318-0","article-title":"Male fertility in cyclosporine-treated renal transplant patients","volume":"145","author":"Haberman","year":"1991","journal-title":"J Urol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib894","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0041-1345(02)03994-5","article-title":"Impact of renal transplantation on gonadal function in male uremic patients-our experience","volume":"35","author":"Aulakh","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib895","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/014850199262995","article-title":"Male fertility of kidney transplant patients with one to ten years of evolution using a conventional immunosuppressive regimen","volume":"42","author":"De Celis","year":"1999","journal-title":"Arch Androl"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib896","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2265.1981.tb00642.x","article-title":"Testicular function after renal transplantation","volume":"14","author":"Handelsman","year":"1981","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib897","first-page":"144","article-title":"Testicular function after renal transplantation: Comparison of cyclosporin A with azathioprine and prednisone combination regimes","volume":"22","author":"Handelsman","year":"1984","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib898","first-page":"146","article-title":"A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function","volume":"10","author":"Holdsworth","year":"1978","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib899","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2605.1996.tb00524.x","article-title":"Assessment of sperm motion characteristics in infertile renal transplant recipients using computerized analysis","volume":"19","author":"Eid","year":"1996","journal-title":"Int J Androl"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib900","first-page":"131","article-title":"Spermatogenesis before and after renal transplant","volume":"25","author":"Rodrigues Netto","year":"1980","journal-title":"Int J Fertil"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib901","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.TP.0000079830.03841.9E","article-title":"Rapamycin-induced oligospermia","volume":"76","author":"Bererhi","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib902","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1432-2277.2006.00423.x","article-title":"Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: An overview","volume":"20","author":"Huyghe","year":"2007","journal-title":"Transpl Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib903","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1439-0272.2007.00787.x","article-title":"Azoospermia in a renal transplant recipient during sirolimus (rapamycin) treatment","volume":"39","author":"Skrzypek","year":"2007","journal-title":"Andrologia"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib904","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1600-6143.2008.02267.x","article-title":"Sirolimus may reduce fertility in male renal transplant recipients","volume":"8","author":"Zuber","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib905","doi-asserted-by":"crossref","first-page":"25572","DOI":"10.1074\/jbc.M002218200","article-title":"Stem cell factor\/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase\/p70 S6 kinase pathway in spermatogonia","volume":"275","author":"Feng","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib906","first-page":"57","article-title":"Report from the National Transplantation Pregnancy Registry: Outcomes of pregnancy after transplantation","author":"Armenti","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib907","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1681\/ASN.2007030345","article-title":"Psychosocial aspects of chronic disease: ESRD as a paradigmatic illness","volume":"18","author":"Cukor","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib908","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/j.ackd.2007.07.007","article-title":"Depression in end-stage renal disease patients: A critical review","volume":"14","author":"Kimmel","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib909","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2215\/CJN.00030505","article-title":"Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: Contribution of reverse causality","volume":"1","author":"Boulware","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib910","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2190\/M1TX-V1EJ-E43L-RKLF","article-title":"The Beck Depression Inventory as a screening device for maJor depression in renal dialysis patients","volume":"18","author":"Craven","year":"1988","journal-title":"Int J Psychiatry Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib911","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/sj.ki.5000308","article-title":"The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients","volume":"69","author":"Hedayati","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib912","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1523-1755.2004.00977.x","article-title":"Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS","volume":"66","author":"Lopes","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib913","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/ajkd.2003.50029","article-title":"The prevalence and treatment of depression among patients starting dialysis","volume":"41","author":"Watnick","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib914","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0272-6386(03)00740-6","article-title":"Quality of life after kidney and pancreas transplantation: A review","volume":"42","author":"Joseph","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib915","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0272-6386(00)70009-6","article-title":"Differences in quality of life across renal replacement therapies: A meta-analytic comparison","volume":"35","author":"Cameron","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib916","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/01.TP.0000092955.28529.1E","article-title":"Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation","volume":"76","author":"Karam","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib917","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.transproceed.2007.09.030","article-title":"Quality of life in hemodialysis, peritoneal dialysis, and transplantation patients","volume":"39","author":"Sayin","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib918","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.transproceed.2003.11.021","article-title":"Depression levels before and after renal transplantation","volume":"36","author":"Akman","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib919","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.transproceed.2007.05.011","article-title":"Depression and quality of life in living related renal transplantation","volume":"39","author":"Virzi","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib920","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.transproceed.2007.03.088","article-title":"Anxiety and depression: A comparison between renal transplant recipients and hemodialysis patients","volume":"39","author":"Karaminia","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib921","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1397-3142.2003.00124.x","article-title":"The use of art therapy to detect depression and post-traumatic stress disorder in pediatric and young adult renal transplant recipients","volume":"8","author":"Wallace","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib922","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.transproceed.2007.04.002","article-title":"Anxiety and depression are correlated with higher morbidity after kidney transplantation","volume":"39","author":"Noohi","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib923","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.transproceed.2006.08.069","article-title":"The influence of posttransplant anxiety on the long-term health of patients","volume":"38","author":"Perez-San-Gregorio","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib924","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1399-3046.2007.00765.x","article-title":"Identification of medication non-adherence factors in adolescent transplant patients: The patient\u2019s viewpoint","volume":"11","author":"Bullington","year":"2007","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib925","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1097\/01.ASN.0000069268.63375.4A","article-title":"Hospitalized psychoses after renal transplantation in the United States: Incidence, risk factors, and prognosis","volume":"14","author":"Abbott","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib926","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.ajkd.2008.01.010","article-title":"Depressive disorder in renal transplantation: An analysis of Medicare claims","volume":"51","author":"Dobbels","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib927","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1034\/j.1399-0012.2002.02080.x","article-title":"Emotional issues after kidney transplantation: A prospective psychotherapeutic study","volume":"16","author":"Baines","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib928","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/j.1523-1755.2004.00594.x","article-title":"Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants","volume":"65","author":"Baines","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib929","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/ajkd.1998.v31.pm9469504","article-title":"Interactions between cyclosporine and newer antidepressant medications","volume":"31","author":"Vella","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib930","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1525-1497.1997.00076.x","article-title":"Case-finding instruments for depression. Two questions are as good as many","volume":"12","author":"Whooley","year":"1997","journal-title":"J Gen Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib931","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-127-5-199709010-00008","article-title":"Formulating questions and locating primary studies for inclusion in systematic reviews","volume":"127","author":"Counsell","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib932","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib933","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/sj.ki.5001875","article-title":"Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"70","author":"Uhlig","year":"2006","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib934","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib935","article-title":"Grading and the GRADE instrument. In Second Guidelines International Network (G-I-N) Conference Wellington","author":"Farquhar","year":"2004","journal-title":"New Zealand"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib936","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE proJect","volume":"12","year":"2003","journal-title":"Qual Saf Health Care"},{"key":"10.1111\/j.1600-6143.2009.02834.x_bib937","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-139-6-200309160-00013","article-title":"Standardized reporting of clinical practice guidelines: A proposal from the Conference on Guideline Standardization","volume":"139","author":"Shiffman","year":"2003","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2009.02834.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522019335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522019335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2009.02834.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:49:53Z","timestamp":1761626993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522019335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":940,"alternative-id":["S1600613522019335"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02834.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02834.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}